Skip to main content
Erschienen in: Sports Medicine 2/2019

Open Access 29.10.2018 | Systematic Review

Aerobic Training Protects Cardiac Function During Advancing Age: A Meta-Analysis of Four Decades of Controlled Studies

verfasst von: Alexander J. Beaumont, Fergal M. Grace, Joanna C. Richards, Amy K. Campbell, Nicholas F. Sculthorpe

Erschienen in: Sports Medicine | Ausgabe 2/2019

Abstract

Background

In contrast to younger athletes, there is comparatively less literature examining cardiac structure and function in older athletes. However, a progressive accumulation of studies during the past four decades offers a body of literature worthy of systematic scrutiny.

Objectives

We conducted a systematic review, meta-analysis and meta-regression of controlled echocardiography studies comparing left ventricular (LV) structure and function in aerobically trained older athletes (> 45 years) with age-matched untrained controls, in addition to investigating the influence of chronological age.

Methods

Electronic databases were searched from inception to January 2018 before conducting a random-effects meta-analysis to calculate pooled differences in means, effect size and 95% confidence intervals (CIs). Study heterogeneity was reported using Cochran’s Q and I2 statistic.

Results

Overall, 32 studies (644 athletes; 582 controls) were included. Athletes had greater LV end-diastolic diameter (3.65 mm, 95% CI 2.66–4.64), interventricular septal thickness (1.23 mm, 95% CI 0.85–1.60), posterior wall thickness (1.20 mm, 95% CI 0.83–1.56), LV mass (72 g, 95% CI 46–98), LV mass index (28.17 g·m2, 95% CI 19.84–36.49) and stroke volume (13.59 mL, 95% CI 7.20–19.98) (all p < 0.01). Athletes had superior global diastolic function [ratio of early (E) to late (A) mitral inflow velocity (E/A) 0.18, 95% CI 0.13–0.24, p < 0.01; ratio of early (e′) to late (a′) diastolic annular tissue velocity (e′/a′) 0.23, 95% CI 0.06–0.40, p = 0.01], lower A (−8.20 cm·s−1, 95% CI −11.90 to −4.51, p < 0.01) and a′ (−0.72 cm·s−1, 95% CI −1.31 to −0.12, p = 0.02), and more rapid e′ (0.96 cm·s−1, 95% CI 0.05–1.86, p = 0.04). Meta-regression for chronological age identified that athlete–control differences, in the main, are maintained during advancing age.

Conclusions

Athletic older men have larger cardiac dimensions and enjoy more favourable cardiac function than healthy, non-athletic counterparts. Notably, the athlete groups maintain these effects during chronological ageing.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s40279-018-1004-3) contains supplementary material, which is available to authorized users.
Key Points
Trained older men have larger left ventricular morphology and superior diastolic function than age-matched untrained yet healthy controls, determined by conventional echocardiography.
The functional adaptations noted in older athletes are, in the main, maintained with chronological age from middle and into older age.
Aerobic exercise is an effective non-pharmacological therapy to preserve cardiac function during ageing and is maintained with continuous exercise therapy.

1 Introduction

It is well established that a lifestyle consisting of regular physical exertion is associated with reduced cardiovascular risk and all-cause mortality across the age spectrum [1, 2]. Despite this, epidemiological studies consistently identify older adults as the least physically active demographic where few achieve the recommended levels of physical activity required to accrue health benefits [3]. Studies of ageing athletes observe relatively high levels of cardiovascular reserve (maximal aerobic capacity) compared with their sedentary counterparts [4]. In this respect, the ‘masters athlete’ model offers a unique non-pharmacological model to differentiate the inexorable from the preventable mechanisms of cardiovascular ageing. In studies of cardiovascular function, endurance-trained masters athletes have superior functional capacity and cardiovascular reserve to their sedentary peers, and are comparable in these respects to non-athletes who are years (and often decades) their junior. As this is not the focus of the present review, we direct readers to the eminent works from Professor Benjamin Levine (University of Texas) and Professor Douglas R. Seals (University of Colorado) [5, 6].
A major limitation of this area, however, is that randomised controlled trials of life-long exercise are highly unlikely, and therefore researchers must rely on evidence from animal models and controlled observational studies to further our understanding of the effects of age on cardiac structure and function [5, 79]. Indeed, the pleiotropic benefits of aerobic endurance exercise have been acknowledged as a potential non-pharmacological mitigant to deterioration of left ventricular (LV) diastolic function [10]. Although this body of evidence is encouraging, it is often hampered by small sample sizes in controlled observational studies which suffer from low statistical power, methodological inconsistencies and untested external validity. In contrast to a wealth of data in younger cohorts < 45 years, including several meta-analyses of LV, right ventricular (RV) and left atrial (LA) structure and function in both male [1117] and female [14, 17, 18] athletes, there have been narrative reviews [10, 1921] but no systematic synthesis of evidence in older athletes relative to matched, untrained controls. Further, in the absence of prospective investigations of multiple decades in duration, quantifying the influence of chronological age on exercise-related morphological and functional adaptations must be realised through cross-sectional studies, across the age spectrum from middle to older age (i.e. > 45 years).
In light of this, we undertook a systematic review and meta-analysis of studies using echocardiography to (1) compare LV morphology and systolic and diastolic function in older athletes versus age-matched sedentary but otherwise healthy controls and (2) employ meta-regression to explore the influence of chronological age on cardiac structure and function in the ageing athlete.

2 Methods

The systematic search processes, evaluation, analysis, and reporting were conducted and presented in accordance with the Preferred Reporting Items for Systematic review and Meta-Analyses (PRISMA) guidelines for reporting systematic reviews and meta-analyses [22].

2.1 Information Sources and Search Strategy

An electronic database search was designed by two authors (AB and NS), who conducted an independent literature search of PubMed (title and abstract), MEDLINE (title) and ScienceDirect (title, abstract and keywords) for published, English-language journal articles from inception to 11 January 2018 (see Electronic Supplementary Material Appendix S1 for the PubMed database search).

2.2 Inclusion Criteria

Studies were eligible for quantitative analysis when meeting the following criteria: (1) study participants were male; (2) mean participant age ≥ 45 years; (3) aged-matched control group; (4) athlete groups were aerobic/endurance trained; (5) control groups were untrained; (6) participants were reported as free from cardiovascular diseases; (7) the study was observational in design and data were recorded at a single time point (including recruitment data from intervention studies); (8) studies used echocardiography; and (9) studies assessed cardiac strain using two-dimensional speckle tracking echocardiography (STE).
We elected to include only endurance athletes participating in predominantly dynamic aerobic activity (for example, distance running, cycling, and rowing). Where study information was unclear, corresponding authors were contacted by email.

2.3 Study Selection and Data Extraction

Following an initial literature search (AB), study data were independently extracted by AB and AC and cross-checked by an arbitrator (NS). Extracted data were entered into a spreadsheet (Microsoft® Excel 2016, Microsoft Corporation, Redmond, WA, USA). Twenty-one measures of LV, RV and LA structure and function were recorded. Cardiac structure measures included (1) interventricular septum (IVS) thickness, (2) LV posterior wall thickness (PWT), (3) left ventricular end-diastolic diameter (LVEDD), (4) relative wall thickness (RWT), (5) left ventricular mass (LVM), (6) LVM index (LVMi), (7) left ventricular end-diastolic volume (LVEDV), (8) right ventricular end-diastolic diameter (RVEDD), and (9) left atrial diameter (LAD). LV systolic function measures by conventional echocardiography were (10) ejection fraction (EF), (11) fractional shortening (FS), (12) stroke volume (SV), (13) systolic annular tissue velocity (s′), and by two-dimensional STE, (14) global longitudinal strain (GLS). Diastolic function measures were (15) early mitral inflow velocity (E), (16) late mitral inflow velocity (A), (17) ratio of early to late mitral inflow velocity (E/A), (18) early diastolic annular tissue velocity (e′), (19) late diastolic annular tissue velocity (a′), (20) ratio of early to late diastolic annular tissue velocity (e′/a′), and (21) ratio of early mitral inflow velocity to early diastolic annular tissue velocity (E/e′).
Multiple segment reports for mitral annular tissue velocities (septal, lateral wall, inferior wall, anterior wall) were combined to obtain a global value. We included studies employing either pulsed-wave Doppler or colour Doppler techniques to obtain tissue velocities. Data for RWT included both descriptions of RWT and thickness/radius ratio. We elected to only include studies that scaled LVM to body surface area (BSA) in line with current echocardiographic recommendations [23]. GLS was deemed as a global value from the average of multiple segments, and E/e′ was considered to be an estimate of LV filling pressure [24].
When unsuccessful attempts were made to contact authors, data were extracted from study figures. Study means ± standard deviation (SD) were recorded for all variables; where studies reported the standard error of the mean (SEM), we applied a manual conversion using the formula SD = SEM × √N, where N is the number of participants. Likewise, when median and range were reported, a manual conversion was applied to convert data into mean and SD, in accordance with the study sample size [25]. For each study, the mean age of athlete and control groups were averaged to obtain a pooled mean. Study quality was assessed for each individual study using a 17-point checklist (Electronic Supplementary Material Table S1) adapted for specificity for this meta-analysis from a previously published checklist used in a similar study of young athletes [13].

2.4 Statistical Analyses

Meta-analyses were executed using Comprehensive Meta-Analysis (Biostat, V 2.2.064, Englewood, NJ, USA). Pooled data using a random-effects model were used to investigate athlete–control differences. Differences in means were calculated for each individual study, and a summary of overall difference in means recorded for all variables. Differences in means in a positive direction indicated greater magnitude of LV structure or function in athletes, with negative direction favouring a greater magnitude in controls. Heterogeneity was reported using Cochran’s Q and I2 statistic and classed as either low, moderate, or high at 25%, 50%, and 75%, respectively [26]. Using pooled athlete and control age (continuous moderator variable), we conducted random-effects (method of moments) meta-regression analysis to examine the relationship between differences in means with chronological age. Meta-regression analysis was performed where there were ten or more studies [27]. Publication bias was addressed using Egger’s regression intercept [28] to test for asymmetry and interpreted conservatively [27]. Statistical significance was granted at p ≤ 0.05.

3 Results

3.1 Search Outcome

Figure 1 illustrates the systematic filtration process. The electronic database search resulted in 597 records, which were exported to referencing software (Zotero, Fairfax, VA, USA) to manage the systematic process.
Thirty-two studies including 1226 participants [644 athletes (59 ± 8 years) and 582 controls (59 ± 8 years); mean age range 46–74 years] met the inclusion criteria for quantitative analyses [7, 2959]. This allowed for the following comparisons [number of studies presented in parentheses; study names for each comparison can be found in supplementary forest plots (Electronic Supplementary Material Figs. S1–S21)]: IVS (n = 18), PWT (n = 18), LVEDD (n = 23), LVM (n = 10), LVMi (n = 20), RWT (n = 11), LVEDV (n = 10), RVEDD (n = 3), LAD (n = 5), EF (n = 15), FS (n = 11), SV (n = 7), s′ (n = 14), GLS (n = 5), E (n = 22), A (n = 20), E/A (n = 23), e′ (n = 14), a′ (n = 13), e′/a′ (n = 7), E/e′ (n = 8) (Fig. 1).
Summarised participant anthropometrics, systolic and diastolic blood pressure and heart rate are presented in Table 1. Characteristics of athlete training regimes and control activity levels are reported in Table 2. LV, RV and LA structure and systolic and diastolic function data for control and athlete groups are presented in Tables 3, 4, and 5, respectively. Table 6 describes the meta-analyses data for athlete–control comparisons including between-study heterogeneity. Electronic Supplementary Material Figs. S1–S36 present forest plots of athlete–control comparisons and meta-regression figures of the athlete–control differences moderated for chronological age.
Table 1
Summary of studies and anthropometric data
References
Study group (n)
Age (years)
Height (cm)
Mass (kg)
BMI (kg·m2)
BSA (m2)
HR (beats·min−1)
SBP (mmHg)
DBP (mmHg)
Study quality
Child et al. [33]
Control (12)
56.3 ± 7.8
1.93 ± 0.08
62 ± 11
12
Runners (9)
53.7 ± 10.6
1.78 ± 0.13
49 ± 7
D’Andrea et al. [35]
Control (25)
47.4 ± 2.2
1.88 ± 0.4
73 ± 8
126 ± 6
85 ± 3
14
Swimmers (40)
48.2 ± 3.4
1.89 ± 0.5
50 ± 4
117 ± 9
79 ± 5
Giada et al. [42]
Control (12)
58.0 ± 6.0
1.92 ± 0.1
69 ± 10
146 ± 17
83 ± 8
13
Cyclists (12)
55.0 ± 5.0
1.86 ± 0.1
55 ± 6
139 ± 14
87 ± 8
Kozakova et al. [44]
Control (16)
46.5 ± 16.0
82 ± 20
129 ± 12
67 ± 10
7
Runners, triathletes (16)
53.1 ± 20.0
72 ± 8
135 ± 16
70 ± 12
Lee et al. [45]
Control (9)
54.8 ± 4.3
182 ± 3
81.7 ± 5.0
24.8 ± 2.1
60 ± 4
114 ± 10
70 ± 10
13
Cyclists, triathletes, speed-skaters (12)
53.8 ± 4.1
177 ± 7
75.1 ± 4.8
23.9 ± 2.1
57 ± 7
112 ± 10
69 ± 10
Lindsay and Dunn [46]
Control (45)
52.0
1.83 ± 0.27
129 ± 17
77 ± 13
14
Runners (45)
52.0 ± 11.4
1.88 ± 0.13
129 ± 16
77 ± 8
Maufrais et al. [50]
Control (26)
56.0 ± 6.0
175 ± 6
80.9 ± 22.4
26.3 ± 0.2
1.95 ± 0.22
65 ± 10
128 ± 11
82 ± 7
14
Runners, triathletes, cyclists (35)
54.0 ± 7.0
175 ± 14
73.7 ± 7.9
25.2 ± 8.6
1.88 ± 0.15
56 ± 9
127 ± 11
80 ± 9
Northcote et al. [54]
Control (17)
56.0 ± 7.0
174 ± 8
74.0 ± 8.0
24.5 ± 3.5
72 ± 10
135 ± 23
12
Runners (18)
56.0 ± 7.0
175 ± 5
64.0 ± 5.0
22.4 ± 0.1
51 ± 7
125 ± 15
Nottin et al. [55]
Control (14)
55.9 ± 4.1
173 ± 4
80.4 ± 5.5
1.94 ± 0.08
73 ± 10
135 ± 9
83 ± 7
13
Cyclists (14)
58.6 ± 4.8
173 ± 7
73.0 ± 9.4
1.86 ± 0.15
63 ± 6
141 ± 6
83 ± 8
Sagiv et al. [57]
Control (15)
60.1 ± 1.1
173 ± 5
72.1 ± 3.0
81 ± 8
122 ± 6
82 ± 6
12
Aerobic athletes (15)
59.3 ± 1.1
175 ± 7
71.4 ± 3.2
69 ± 9
117 ± 7
77 ± 10
Nishimura et al. [53]
Control (15)
46.9 ± 3.3
1.62 ± 0.05
60 ± 8
127 ± 13
75 ± 9
14
Bicyclists (29)
45.6 ± 2.3
1.78 ± 0.10
54 ± 7
120 ± 10
78 ± 8
Baldi et al. [29]
Control (20)
65.7 ± 3.7
176 ± 4
77.5 ± 10.3
25.1 ± 2.6
1.96 ± 0.15
63 ± 9
140 ± 8
78 ± 17
11
Endurance athletes (19)
65.2 ± 4.2
175 ± 6
70.1 ± 6.8
23.1 ± 1.8
1.82 ± 0.42
56 ± 6
126 ± 7
80 ± 6
Bouvier et al. [31]
Control (12)
74.9 ± 2.4
175 ± 6
78.4 ± 11.0
25.8 ± 3.5
1.93 ± 0.13
69 ± 9
148 ± 14
81 ± 7
9
Orienteers, runners (10)
72.8 ± 2.9
179 ± 3
72.5 ± 8.7
22.6 ± 2.1
1.90 ± 0.13
58 ± 11
151 ± 26
78 ± 7
Carrick-Ranson et al. [32]
Control (27)
66.0 ± 5.0
176 ± 7
87.0 ± 16.0
28.0 ± 5.0
69 ± 11
11
Cyclists, runners, dual/triathletes (17)
66.0 ± 4.0
176 ± 6
75.0 ± 10.0
24.0 ± 2.0
62 ± 10
Di Bello et al. [36]
Control (11)
69.7 ± 8.4
169 ± 4
64.8 ± 9.5
1.80 ± 0.10
83 ± 21
145 ± 8
81 ± 3
13
Runners (12)
65.7 ± 7.1
176 ± 8
69.2 ± 9.1
1.90 ± 0.20
68 ± 15
145 ± 6
81 ± 2
Galetta et al. [40]
Control (16)
66.9 ± 4.6
177 ± 12
77.3 ± 8.7
24.6 ± 1.1
68 ± 7
134 ± 8
82 ± 4
15
Runners (16)
67.6 ± 4.5
177 ± 15
74.8 ± 6.5
23.7 ± 0.7
54 ± 7
125 ± 6
79 ± 8
Galetta et al. [39]
Control (25)
68.3 ± 3.2
176 ± 7
76.8 ± 5.6
24.5 ± 1.1
68 ± 6
133 ± 6
82 ± 4
15
Runners (25)
69.4 ± 3.8
175 ± 7
75.9 ± 5.6
24.7 ± 0.7
54 ± 5
130 ± 5
81 ± 6
Gates et al. [41]
Control (11)
65.0 ± 6.6
177 ± 7
85.0 ± 16.6
2.02 ± 0.17
59 ± 7
119 ± 17
74 ± 7
13
Aerobic athletes (12)
68.0 ± 6.9
174 ± 3
74.0 ± 6.9
1.89 ± 0.17
48 ± 7
128 ± 17
76 ± 10
Gates et al. [41]
Control (24)
51.0 ± 4.9
177 ± 5
85.0 ± 14.7
2.01 ± 0.15
60 ± 10
116 ± 10
73 ± 5
13
Aerobic athletes (16)
50.0 ± 8.0
176 ± 8
73.0 ± 8.0
1.89 ± 0.16
47 ± 8
112 ± 8
68 ± 4
Jungblut et al. [43]
Control (12)
69.0 ± 3.0
173 ± 9
79.0 ± 16.0
26 ± 3.4
69 ± 17
144 ± 17
82 ± 9
13
Runners (12)
69.0 ± 5.0
173 ± 5
66.0 ± 6.2
22 ± 1.7
57 ± 8
141 ± 15
77 ± 6
Schmidt et al. [58]
Control (26)
68.2 ± 3.2
176 ± 3
84 .1 ± 11.1
27.2 ± 3.8
61 ± 9
129 ± 14
77 ± 9
14
Soccer players (17)
68.1 ± 2.1
178 ± 2
78.1 ± 8.2
24.6 ± 2.3
55 ± 8
127 ± 14
75 ± 9
Seals et al. [59]
Control (6)
63.0 ± 3.0
181 ± 2
81.3 ± 7.4
2.01 ± 0.07
71 ± 7
130 ± 7
11
Runners (8)
64.0 ± 6.0
173 ± 6
63.8 ± 5.7
1.76 ± 0.08
50 ± 6
137 ± 14
Molmen et al. [52]
Control (10)
71.7 ± 1.3
76.5 ± 9.4
25 ± 2.5
66 ± 9
145 ± 17
81 ± 9
15
Cross–country skiers (11)
74.3 ± 1.8
74.5 ± 8.3
23 ± 1.9
53 ± 8
122 ± 16
71 ± 9
Cottini et al. [34]
Control (15)
61.0 ± 7.0
73 ± 8
128 ± 10
80 ± 8
6
Aerobic athletes (15)
60.0 ± 10.0
58 ± 8
120 ± 9
75 ± 8
Olsen et al. [56]
Control (11)
66.3 ± 3.8
175 ± 4
75.1 ± 4.4
24.6 ± 1.6
63 ± 7
127 ± 10
78 ± 5
15
Runners (17)
65.0 ± 4.6
176 ± 4
71.1 ± 5.9
23.1 ± 1.6
54 ± 8
138 ± 18
76 ± 14
Fleg et al. [38]
Control (23)
63.0 ± 6.0
177 ± 6
79.7 ± 11.9
25.3 ± 2.8
1.97 ± 0.16
72 ± 9
131 ± 17
79 ± 11
15
Runners (16)
65.0 ± 8.0
176 ± 6
70.7 ± 8.1
22.8 ± 2.2
1.86 ± 0.12
56 ± 12
125 ± 17
74 ± 14
Miki et al. [51]
Control (14)
49.0 ± 7.6
1.62 ± 0.14
61 ± 9
122 ± 10
10
Cyclists (35)
49.4 ± 6.4
1.82 ± 0.10
51 ± 7
125 ± 9
Matelot et al. [48]
Control (10)
59.0 ± 3.0
173 ± 5
78.6 ± 12.3
26.1 ± 3.2
70 ± 9
123 ± 8
79 ± 8
12
Runners, cyclists (13)
62.0 ± 3.0
172 ± 4
71.2 ± 6.1
24.1 ± 2.1
57 ± 10
120 ± 12
78 ± 9
Donal et al. [37]
Control (15)
58.9 ± 8.6
175 ± 10
78 ± 12.6
1.90 ± 0.20
141 ± 12
83 ± 7
14
Cyclists (38)
61.5 ± 5.6
173 ± 10
72.3 ± 6.3
1.85 ± 0.10
137 ± 10
80 ± 8
Bohm et al. [30]
Control (33)
46.0 ± 9.0
181 ± 6
80.0 ± 7.0
2.00 ± 0.10
65 ± 11
127 ± 8
78 ± 6
75 ± 7
15
Runners, rowers, triathletes (33)
47.0 ± 8.0
182 ± 5
75.0 ± 6.0
1.96 ± 0.10
48 ± 7
128 ± 8
Grace et al. [7]
Control (22)
62.7 ± 5.2
175 ± 6
89.9 ± 17.2
65 ± 12
139 ± 10
87 ± 5
13
Triathletes, athletics, sprint cyclists, racquet sports (17)
61.1 ± 5.4
173 ± 5.5
79.5 ± 12.3
59 ± 10
131 ± 11
82 ± 7
Maufrais et al. [49]
Control (20)
58.0 ± 7.0
177 ± 6
75.5 ± 11.8
1.92 ± 0.16
65 ± 9
127 ± 11
84 ± 7
13
Cyclists (22)
61.0 ± 7.0
177 ± 7
73.3 ± 8
1.90 ± 0.12
53 ± 9
127 ± 11
84 ± 7
Maessen et al. [47]
Control (13)
55.0 ± 8.0
181 ± 5
88.0 ± 9.0
2.09 ± 0.10
13
Endurance athletes (16)
57.0 ± 8.0
178 ± 8
74.0 ± 8.0
1.91 ± 0.13
Data are means ± standard deviation
BMI body mass index, BSA body surface area, DBP diastolic blood pressure, HR heart rate, SBP systolic blood pressure
Table 2
Descriptions of athlete training programmes and control activity levels as reported by studies
References
Controls
Athletes
Activity levels
Aerobic capacity (mL·min·kg)
Sport
Training frequency
Training volume
Training intensity
Training years
Aerobic capacity (mL·min·kg)
Child et al. [33]
Sedentary
35.0 ± 5.0
Runners
6 athletes
≥ 10
56.0 ± 8.0
D’Andrea et al. [35]
Sedentary
Swimmers
15–20 h/week. 3 h/day swimming and 3 h /week LDR
70–90% heart rate maximum
> 10
Giada et al. [42]
Not engaged in training program
23.0 ± 3.0
Cyclists
213 ± 89 km/week in previous 6 months
21 ± 12
43.0 ± 7.0
Kozakova et al. [44]
Untrained
Runners, triathletes
28 ± 15
Lee et al. [45]
< 2 h of aerobic exercise per week
33.8 ± 5.0
Cyclists, triathletes, speed-skaters
> 6 h/week for the last 3 years
≥ 50% of session performed at ≥ 60% \(\dot{V}{\text{O}}_{{2{ \hbox{max} }}}\)
≥ 3
47.9 ± 4.3
Lindsay and Dunn [46]
Sedentary
Runners
48 ± 25.76 km/week
20 ± 13
Maufrais et al. [50]
No regular training habits
Runners, triathletes, cyclists
> 8 h/week
24 ± 12
Northcote et al. [54]
Sedentary lifestyle. Participation in golf, walking and bowls
Runners
47 ± 23 miles/week
36 ± 7
Nottin et al. [55]
Sedentary
Cyclists
10.5 ± 2.3 h/week
11000 ± 3000 km/year
22 ± 5
Sagiv et al. [57]
Untrained
31.1 ± 2.4
Aerobic athletes
≥ 18 months
42.1 ± 2.1
Nishimura et al. [53]
Sedentary
Bicyclists
1–2 h/day, 4–5 days/week
27 ± 2
Baldi et al. [29]
No participation in endurance sports previous 2 years. Some participation in recreational sports
31.5 ± 5.9
Endurance athletes
21 ± 9
49.7 ± 6.8
Bouvier et al. [31]
Sedentary or moderately active subjects
26.0 ± 5.0
Orienteers, runners
3–7 h/week
Strenuous
15–25 years of age
41.0 ± 7.0
Carrick-Ranson et al. [32]
≤ 60 per week of endurance type training in last 12 months
27.0 ± 4.0
Cyclists, runners, dual/triathletes
4 × 45 min/week (at least 3 h/week) over the previous 12 months
≥ 1
45.0 ± 5.0
Di Bello et al. [36]
Sedentary lifestyles
Runners
1–2 h/day, 5 days/week
Galetta et al. [40]
Sedentary lifestyles with no regular exercise. \(\dot{V}{\text{O}}_{{2{ \hbox{max} }}}\) < 45 mL·min·kg
38.0 ± 7.1
Runners
1–2 h of activity/day, 5 days/week.
LDR 3 days and walking weight training 2 days
≥ 40
63.7 ± 3.4
Galetta et al. [39]
\(\dot{V}{\text{O}}_{{2{ \hbox{max} }}}\) < 35 mL·min·kg
28.0 ± 4.1
Runners
> 5 times/week
Vigorous
37 ± 5
45.7 ± 3.4
Gates et al. [41]
No regular aerobic exercise
29.0 ± 10.0
Aerobic athletes
> 5 times/week
24 ± 4
37.0 ± 6.9
Gates et al. [41]
No regular aerobic exercise
33.0 ± 4.9
Aerobic athletes
> 5 times/week
19 ± 3
51.0 ± 8.0
Jungblut et al. [43]
No sporting participation in previous 6 months
27.0 ± 4.7
Runners
40 miles/week for at least previous 6 months
≥ 6 months
44.0 ± 6.3
Schmidt et al. [58]
Habitually active with no prior participation in structured exercise training
29.0 ± 4.9
Soccer players
1.5 ± 0.6 1-h session/week
26 ± 12 matches (2 × 35 min) per year
52 ± 11
34.1 ± 5.0
Seals et al. [59]
No regular training habits for several years
29.6 ± 3.43
Runners
43 ± 18 miles/week
10 ± 6
50.4 ± 4.8
Molmen et al. [52]
Exercise < 2 times per week in previous year
35.0 ± 5.0
Cross-country skiers
> 5 times/week
≥ 25
49.5 ± 4.5
Cottini et al. [34]
Sedentary
Aerobic athletes
Olsen et al. [56]
Sedentary for at least the last 5 years
29.6 ± 3.1
Runners
4–6 days/week
49 ± 12 km/week
Moderate to high
29 ± 8
46.9 ± 7.0
Fleg et al. [38]
No regular participation in endurance exercise. \(\dot{V}{\text{O}}_{{2{ \hbox{max} }}}\) within 1 SD of age-adjusted sedentary values of BLISA men
30.2 ± 5.0
Runners
160 (median) km/month
16 (median)
47.2 ± 5.9
Miki et al. [51]
Untrained
Cyclists
29
Matelot et al. [48]
≤ 2 h of physical activity throughout life and never involved in competitive sport
33.0 ± 4.3
Runners, cyclists
7 ± 4 h/week
39 ± 4
47.3 ± 7.1
Donal et al. [37]
< 2 h of training per week
Cyclists
> 8 h/week
≥ 5
47.8 ± 5.7
Bohm et al. [30]
≤ 3 h/week
37.0 ± 6.0
Runners, rowers, triathletes
> 10 h/week
29 ± 8
60.0 ± 5.0
Grace et al. [7]
No participation in any formal exercise
Triathletes, athletics, sprint cyclists, racquet sports
Lifelong
Maufrais et al. [49]
No regular training habits
33.3 ± 7.2
Cyclists
9 ± 2 h/week
31 ± 11
42.3 ± 5.9
Maessen et al. [47]
< 10 MET-h/week over the last 20 years
31.6 ± 4.8
Endurance athletes
7.1 (median) h/week
 
60 (median) MET-h/week
≥ 20 (lifelong)
48.0 ± 8.9
Data are presented as mean ± SD unless otherwise stated
BLISA Baltimore Longitudinal Study of Aging, LDR long-distance running, MET metabolic equivalent of task, SD standard deviation, \(\dot{V}O_{2max}\) maximal oxygen uptake
Table 3
Summary of athlete and control groups included for measures of cardiac structure
References
Study group (n)
IVS (mm)
PWT (mm)
LVEDD (mm)
LVM (g)
LVMi (g·m2)
RWT
LVEDV (mL)
LAD (mm)
RVEDD (mm)
Child et al. [33]
Control (12)
Runners (9)
10.5 ± 1.5
11.2 ± 2.2
9.9 ± 0.8
10.3 ± 0.9
48.3 ± 4.5
52.1 ± 3.7
111.7 ± 23.8
153.9 ± 27.4
D’Andrea et al. [35]
Control (25)
Swimmers (40)
9.3 ± 1.1
10.2 ± 2.1
8.4 ± 2.1
9.4 ± 2.1
47.4 ± 4.7
56.4 ± 4.7
0.43 ± 0.04
0.39 ± 0.04
21.2 ± 2.8
25.2 ± 3.8
Giada et al. [42]
Control (12)
Cyclists (12)
93.0 ± 12.0
134.0 ± 19.0
Kozakova et al. [44]
Control (16)
Runners, triathletes (16)
9.8 ± 0.0
13.6 ± 0.0 (a)
9.6 ± 0.0
12.5 ± 0.0 (a)
49.0 ± 8.0
52.8 ± 4.0
191.4 ± 56.0
348.6 ± 69.2
94.9 ± 22.0
184.6 ± 33.6
Lee et al. [45]
Control (9)
Cyclists, triathletes, speed-skaters (12)
9.0 ± 2.0
9.0 ± 3.0
10.0 ± 6.0
10.0 ± 4.0
45.0 ± 10.0
45.0 ± 8.0
58.4 ± 8.0
90.3 ± 15.0
0.36 ± 0.05
0.38 ± 0.01
108.0 ± 22.0
97.0 ± 29.0
Lindsay and Dunn [46]
Control (45)
Runners (45)
9.0 ± 2.0
12.0 ± 2.0
9.0 ± 1.3
11.0 ± 1.3
48.0 ± 4.7
52.0 ± 4.0
97.0 ± 20.1
141.0 ± 33.5
0.37 ± 0.07
0.42 ± 0.07
Maufrais et al. [50]
Control (26)
Runners, triathletes, cyclists (35)
50.0 ± 5.0
55.0 ± 4.0
Northcote et al. [54]
Control (17)
Runners (18)
11.0 ± 0.8
12.2 ± 2.2
10.8 ± 0.9
12.1 ± 1.9
46.9 ± 4.1
46.8 ± 6.6
221.0 ± 36.7
265.0 ± 84.2
118.0 ± 17.6
151.0 ± 50.4
0.46 ± 0.06
0.53 ± 0.11
104.0 ± 18.4
112.0 ± 24.1
Nottin et al. [55]
Control (14)
Cyclists (14)
98.0 ± 22.0
104.0 ± 23.0
Nishimura et al. [53]
Control (15)
Bicyclists (29)
8.6 ± 1.1
11.0 ± 1.5
8.4 ± 1.0
10.1 ± 1.4
48.6 ± 2.4
54.1 ± 3.0
147.0 ± 23.0
222.0 ± 35.0
132.0 ± 15.0
173.0 ± 24.0
40.0 ± 5.6
31.1 ± 5.4
Baldi et al. [29]
Control (20)
Endurance athletes (19)
7.1 ± 0.4
8.6 ± 0.3
7.3 ± 0.3
8.9 ± 0.3
49.6 ± 4.2
54.1 ± 3.1
155.0 ± 6.4
174.7 ± 30.6
78.4 ± 24.3
94.3 ± 17.5
34.7 ± 8.6
35.2 ± 4.4
Bouvier et al. [31]
Control (12)
Orienteers, runners (10)
11.0 ± 1.3
11.0 ± 1.5
11.0 ± 1.4
12.0 ± 0.8
46.0 ± 6.0
48.0 ± 4.0
121.0 ± 27.0
136.0 ± 24.0
39.0 ± 4.0
39.0 ± 4.0
Carrick-Ranson et al. [32]
Control (27)
Cyclists, runners, dual/triathletes (17)
55.0 ± 5.0
55.0 ± 6.0
166.0 ± 40.0
203.0 ± 41.0
Di Bello et al. [36]
Control (11)
Runners (12)
10.9 ± 2.3
13.1 ± 1.9
10.6 ± 1.4
12.5 ± 1.9
48.1 ± 5.2
50.7 ± 5.1
225.2 ± 62.7
318.9 ± 81.2
123.2 ± 29.1
165.1 ± 36.7
34.0 ± 3.2
35.9 ± 4.8
Galetta et al. [40]
Control (16)
Runners (16)
10.1 ± 0.7
12.2 ± 1.4
9.6 ± 0.8
11.9 ± 1.2
49.1 ± 4.6
53.2 ± 4.2
148.2 ± 12.5
258.2 ± 14.2
Galetta et al. [39]
Control (25)
Runners (25)
10.1 ± 0.6
12.2 ± 1.3
9.4 ± 0.7
11.9 ± 1.1
49.7 ± 4.4
53.8 ± 4.4
146.2 ± 11.5
256.2 ± 12.8
Gates et al. [41]
Control (11)
Aerobic athletes (12)
85.0 ± 16.6
106.0 ± 17.3
0.40 ± 0.04
0.38 ± 0.04
Gates et al. [41]
Control (24)
Aerobic athletes (16)
85.0 ± 9.8
98.0 ± 12.0
0.37 ± 0.04
0.35 ± 0.02
Jungblut et al. [43]
Control (12)
Runners (12)
9.0 ± 1.0
9.0 ± 2.0
10.0 ± 2.0
10.0 ± 1.0 (↔
47.0 ± 5.0
53.0 ± 6.0
51.0 ± 7.8
61.0 ± 13.0
0.40 ± 0.08
0.40 ± 0.07
Schmidt et al. [58]
Control (26)
Soccer players (17)
10.0 ± 2.0
10.0 ± 1.0
10.0 ± 2.0
9.0 ± 1.0
49.0 ± 5.0
50.0 ± 5.0
85.4 ± 17.3
90.6 ± 21.2
97.0 ± 20.0
116.0 ± 22.0
Seals et al. [59]
Control (6)
Runners (8)
0.35 ± 0.02
0.34 ± 0.06
Cottini et al. [34]
Control (15)
Aerobic athletes (15)
9.1 ± 1.0
9.4 ± 0.8
8.5 ± 1.1
8.8 ± 0.7
52.8 ± 3.1
54.0 ± 2.0
138.0 ± 8.4
146.0 ± 8.4
36.0 ± 3.9
35.0 ± 4.8
Olsen et al. [56]
Control (11)
Runners (17)
45.0 ± 2.0
50.0 ± 4.0
129.0 ± 20.0
188.0 ± 39.0
68.0 ± 11.0
101.0 ± 20.0
0.38 ± 0.04
0.37 ± 0.06
89.0 ± 18.0
122.0 ± 15.0
Fleg et al. [38]
Control (23)
Runners (16)
102.0 ± 30.0
105.0 ± 30.0
0.48 ± 0.10
0.42 ± 0.10
Miki et al. [51]
Control (14)
Cyclists (35)
107.5 ± 17.4
180.9 ± 34.2
0.39 ± 0.04
0.47 ± 0.09
Matelot et al. [48]
Control (10)
Runners, cyclists (13)
9.4 ± 1.4
9.9 ± 1.6
7.9 ± 1.5
9.6 ± 1.8
48.6 ± 2.8
52.5 ± 3.7
Donal et al. [37]
Control (15)
Cyclists (38)
9.0 ± 1.0
11.0 ± 1.0
10.0 ± 2.0
11.0 ± 1.0
47.0 ± 4.0
48.0 ± 4.0
79.3 ± 15.7
104.7 ± 17.2
117.5 ± 23.2
120.5 ± 20.6
20.5 ± 3.7
20.1 ± 2.7
Bohm et al. [30]
Control (33)
Runners, rowers, triathletes (33)
10.3 ± 0.8
11.7 ± 0.7
9.2 ± 1.1
10.4 ± 1.1
50.0 ± 4.2
56.4 ± 2.2
27.3 ± 4.3
34.1 ± 3.8
Sagiv et al. [57]
Control (15)
Aerobic athletes (15)
100.7 ± 6.2
108.1 ± 5.8
Molmen et al. [52]
Control (10
Cross-country skiers (11)
102.0 ± 13.0
142.0 ± 21.0
Grace et al. [7]
Control (22)
Triathletes, athletics, sprint cyclists, racquet sports (17)
10.0 ± 1.5
10.0 ± 1.0
9.7 ± 1.3
10.5 ± 1.3
51.4 ± 5.2
52.7 ± 4.8
223.0 ± 48.0
249.0 ± 49.0
89.0 ± 16.9
96.0 ± 16.2
Maessen et al. [47]
Control (13)
Endurance athletes (16)
92.0 ± 15.0
101.0 ± 24.0
Maufrais et al. [49]
Control (20)
Cyclists (22)
51.0 ± 6.0
55.0 ± 5.0
96.0 ± 26.0
127.0 ± 27.0
Data are mean ± standard deviation unless otherwise stated
Statistical significance at p < 0.05
IVS interventricular septal, LAD left atrial diameter, LVEDD left ventricular end-diastolic diameter, LVEDV left ventricular end-diastolic volume, LVM left ventricular mass, LVMi left ventricular mass index, n participant number, PWT posterior wall thickness, RVEDD right ventricular end-diastolic diameter, RWT relative wall thickness
Significantly greater in athletes
Significantly less in athletes
No athlete–control difference
aNot included in meta-analysis
Table 4
Summary of athlete and control groups included for measures of left ventricular systolic function
References
Study group (n)
EF (%)
FS (%)
SV (mL)
s′ (cm·s−1)
GLS (%)
Child et al. [33]
Control (12)
Runners (9)
39.1 ± 4.7
37.8 ± 2.6
D’Andrea et al. [35]
Control (25)
Swimmers (40)
41.7 ± 3.7
46.7 ± 4.7
71.4 ± 3.2
90.1 ± 6.2
9.0 ± 4.0
14.0 ± 3.0
Giada et al. [42]
Control (12)
Cyclists (12)
67.0 ± 4.0
63.0 ± 5.0
Lee et al. [45]
Control (9)
Cyclists, triathletes, speed-skaters (12)
61.2 ± 2.4
61.6 ± 4.0
Maufrais et al. [50]
Control (26)
Runners, triathletes, cyclists (35)
7.3 ± 1.6
7.5 ± 1.6
Northcote et al. [54]
Control (17)
Runners (18)
58.0 ± 7.0
57.0 ± 10.5
27.0 ± 6.2
29.0 ± 5.7
Nottin et al. [55]
Control (14)
Cyclists (14)
61.0 ± 3.0
62.0 ± 2.0
10.5 ± 2.4
9.6 ± 1.8
Sagiv et al. [57]
Control (15)
Aerobic athletes (15)
57.3 ± 6.6
68.1 ± 4.3
Nishimura et al. [53]
Control (15)
Bicyclists (29)
66.0 ± 2.0
63.0 ± 4.0
32.0 ± 2.0
30.0 ± 3.0
93.0 ± 16.0
111.0 ± 15.0
Baldi et al. [29]
Control (20)
Endurance athletes (19)
36.9 ± 5.7
33.7 ± 5.6
7.1 ± 0.9
8.3 ± 1.4
Bouvier et al. [31]
Control (12)
Orienteers, runners (10)
32.0 ± 6.0
31.0 ± 6.0
Carrick-Ranson et al. [32]
Control (27)
Cyclists, runners, dual/triathletes (17)
10.0 ± 1.0
8.0 ± 2.0
Di Bello et al. [36]
Control (11)
Runners (12)
71.8 ± 9.1
75.5 ± 9.3
42.0 ± 8.2
45.2 ± 9.0
65.5 ± 36.1
97.3 ± 23.2
Galetta et al. [40]
Control (16)
Runners (16)
67.2 ± 4.5
64.2 ± 5.2
Galetta et al. [39]
Control (25)
Runners (25)
66.2 ± 4.5
64.2 ± 5.2
8.9 ± 0.8
9.3 ± 0.8
Jungblut et al. [43]
Control (12)
Runners (12)
40.0 ± 6.0
40.0 ± 4.0
Schmidt et al. [58]
Control (26)
Soccer players (17)
54.0 ± 6.0
58.0 ± 4.0
8.7 ± 1.5
8.1 ± 1.3
− 17.7 ± 2.5
− 19.9 ± 2.5
Seals et al. [59]
Control (6)
Runners (8)
36.2 ± 6.9
33.3 ± 8.8
Molmen et al. [52]
Control (10)
Cross-country skiers (11)
58.7 ± 7.2
63.7 ± 4.8
79.0 ± 13.0
102.0 ± 25.0
7.3 ± 0.8
8.2 ± 1.6
Cottini et al. [34]
Control (15)
Aerobic athletes (15)
58.0 ± 2.7
65.0 ± 3.0
Olsen et al. [56]
Control (11)
Runners (17)
59.0 ± 3.0
60.0 ± 4.0
9.4 ± 1.2
8.2 ± 1.5
Fleg et al. [38]
Control (23)
Runners (16)
42.0 ± 9.0
38.0 ± 6.0
Miki et al. [51]
Control (14)
Cyclists (35)
35.6 ± 3.7
34.7 ± 4.2
Matelot et al. [48]
Control (10)
Runners, cyclists (13)
67.1 ± 5.6
62.2 ± 4.3
8.9 ± 1.5
8.6 ± 2.0
− 19.4 ± 2.1
− 19.8 ± 1.9
Donal et al. [37]
Control (15)
Cyclists (38)
62.8 ± 6.8
61.4 ± 6.0
76.2 ± 14.3
74.0 ± 14.5
10.2 ± 1.3
9.2 ± 2.2
− 18.0 ± 2.4
− 17.3 ± 2.2
Bohm et al. [30]
Control (33/32a)
Runners, rowers, triathletes (33/32 a)
9.0 ± 1.5
9.5 ± 1.5
− 18.0 ± 2.0a
− 17.0 ± 2.0a↓
Grace et al. [7]
Control (22)
Triathletes, athletics, sprint cyclists, racquet sports (17)
55.6 ± 8.6
60.9 ± 5.1
67.0 ± 23.0
77.0 ± 9.0
Maessen et al. [47]
Control (13)
Endurance athletes (18)
9.0 ± 1.4
9.3 ± 1.9
Maufrais et al. [49]
Control (20)
Cyclists (22)
7.8 ± 1.4
7.4 ± 1.2
18.1 ± 3.0
17.3 ± 2.1
Data are mean ± standard deviation unless otherwise stated
Statistical significance at p < 0.05
EF ejection fraction, FS fractional shortening, GLS global longitudinal strain, n participant number, s′ systolic tissue velocity, SV stroke volume
Significantly greater in athletes
Significantly less in athletes
No athlete–control different
aDifferent n for GLS
Table 5
Summary of athlete and control groups included for measures of left ventricular diastolic function
References
Study group (n)
E (cm·s−1)
A (cm·s−1)
E/A
e′ (cm·s−1)
a′ (cm·s−1)
e′/a
E/e
D’Andrea et al. [35]
Control (25)
Swimmers (40)
72.0 ± 17.0
88.0 ± 12.0
53.0 ± 14.0
56.0 ± 12.0
1.4 ± 0.5
1.7 ± 0.5
9.0 ± 2.0
16.0 ± 4.0
11.0 ± 2.0
12.0 ± 2.0
0.8 ± 0.4
1.3 ± 0.3
Giada et al. [42]
Control (12)
Cyclists (12)
54.9 ± 12.0
57.0 ± 19.0
57.0 ± 7.0
54.0 ± 15.0
0.9 ± 0.2
1.0 ± 0.3
Lee et al. [45]
Control (9)
Cyclists, triathletes, speed-skaters (12)
73.0 ± 22.0
73.0 ± 16.0
81.0 ± 13.0
62.0 ± 14.0
0.9 ± 0.2
1.2 ± 0.5
Lindsay and Dunn [46]
Control (45)
Runners (45)
70.0 ± 20.0
70.0 ± 20.0
70.0 ± 20.0
60.0 ± 13.0
1.1 ± 0.2
1.2 ± 0.5(↔)
Maufrais et al. [50]
Control (26)
Runners, triathletes, cyclists (35)
70.0 ± 15.0
71.0 ± 15.0
66.0 ± 13.0
64.0 ± 16.0
1.1 ± 0.2
1.2 ± 0.3
7.9 ± 1.3
8.8 ± 1.9
8.4 ± 1.3
7.5 ± 1.3
1.0 ± 0.2
1.2 ± 0.3
Nottin et al. [55]
Control (14)
Cyclists (!4)
53.7 ± 9.7
68.3 ± 13.1
67.4 ± 12.3
66.9 ± 10.6
0.8 ± 0.2
1.0 ± 0.2
11.3 ± 3.2
11.4 ± 2.0
12.4 ± 2.4
11.0 ± 1.7
0.9 ± 0.3
1.1 ± 0.3
4.4 ± 1.1
6.1 ± 2.0
Baldi et al. [29]
Control (20)
Endurance athletes (19)
52.0 ± 10.9
56.6 ± 13.7
56.3 ± 11.2
57.2 ± 13.8
0.9 ± 0.3
1.0 ± 0.3
7.1 ± 1.5
7.7 ± 1.6
10.9 ± 1.5
11.9 ± 1.6
0.7 ± 0.1
0.7 ± 0.1
7.6 ± 2.0
7.5 ± 2.1
Bouvier et al. [31]
Control (12)
Orienteers, runners (10)
0.8 ± 0.2
1.4 ± 0.7
Carrick-Ranson et al. [32]
Control (27)
Cyclists, runners, dual/triathletes (17)
53.7 ± 15.3
53.7 ± 8.7
60.4 ± 20.7
48.8 ± 8.5
0.9 ± 0.2
1.1 ± 0.2
6.9 ± 1.4
6.6 ± 1.5
10.0 ± 2.1
8.5 ± 1.7
0.7 ± 0.1
0.8 ± 0.2
8.0 ± 2.0
9.0 ± 2.0
Di Bello et al. [36]
Control (11)
Runners (12)
77.0 ± 10.0
84.0 ± 13.0
82.0 ± 22.0
74.0 ± 20.0
1.0 ± 0.2
1.2 ± 0.3
Galetta et al. [40]
Control (16)
Runners (16)
56.6 ± 6.3
56.4 ± 6.1
59.8 ± 9.1
55.9 ± 8.5
0.9 ± 0.2
1.0 ± 0.3
Galetta et al. [39]
Control (25)
Runners (25)
56.6 ± 6.3
58.4 ± 6.1
64.8 ± 8.1
45.9 ± 7.5
0.9 ± 0.2
1.2 ± 0.3
9.1 ± 2.3
12.3 ± 2.8
10.7 ± 1.7
8.6 ± 1.6
0.8 ± 0.3
1.4 ± 0.3
Gates et al. [41]
Control (11)
Aerobic athletes (12)
0.9 ± 0.2
1.1 ± 0.3
Gates et al. [41]
Control (24)
Aerobic athletes (16)
1.3 ± 0.4
1.8 ± 0.5
Jungblut et al. [43]
Control (12)
Runners (12)
76.0 ± 22.0
79.0 ± 16.0
75.0 ± 15.0
73.0 ± 19.0
1.0 ± 0.3
1.1 ± 0.2
Schmidt et al. [58]
Control (26)
Soccer players (17)
70.0 ± 10.0
60.0 ± 10.0
70.0 ± 20.0
50.0 ± 10.0
1.1 ± 0.3
1.1 ± 0.2
10.2 ± 2.3
10.0 ± 1.9
11.8 ± 1.9
10.6 ± 2.4
Molmen et al. [52]
Control (10)
Cross-country skiers (11)
58.0 ± 15.0
58.0 ± 14.0
71.0 ± 19.0
49.0 ± 14.0
0.9 ± 0.3
1.3 ± 0.7
6.9 ± 1.5
9.0 ± 2.1
11.5 ± 2.1
10.3 ± 2.8
Cottini et al. [34]
Control (15)
Aerobic athletes (15)
62.2 ± 8.2
80.0 ± 13.6
68.2 ± 5.5
64.9 ± 12.3
0.9 ± 0.1
1.2 ± 0.1
Olsen et al. [56]
Control (11)
Runners (17)
56.0 ± 8.0
63.0 ± 15.0
63.0 ± 12.0
59.0 ± 15.0
0.9 ± 0.2
1.1 ± 0.3
7.8 ± 1.7
8.3 ± 2.5
11.2 ± 1.0
10.1 ± 1.4
7.5 ± 1.4
8.1 ± 2.8
Fleg et al. [38]
Control (23)
Runners (16)
68.0 ± 19.0
56.0 ± 15.0
68.0 ± 19.0
51.0 ± 16.0
1.1 ± 0.4
1.2 ± 0.5
Matelot et al. [48]
Control (10)
Runners, cyclists (13)
69.2 ± 8.3
64.0 ± 11.0
74.6 ± 16.5
58.9 ± 16.7
1.0 ± 0.2
1.1 ± 0.3
9.9 ± 1.9
10.5 ± 2.6
10.8 ± 1.9
10.5 ± 1.1
7.2 ± 1.4
6.3 ± 1.3
Donal et al. [37]
Control (15)
Cyclists (38)
71.5 ± 17.0
61.5 ± 13.3
68.0 ± 19.4
59.7 ± 13.8
1.1 ± 0.5
1.1 ± 0.3
12.3 ± 2.3
10.5 ± 2.3
11.2 ± 2.6
10.9 ± 2.6
6.2 ± 1.7
6.2 ± 2.1
Bohm et al. [30]
Control (33)
Runners, rowers, triathletes (33)
12.0 ± 3.0
11.5 ± 3.0
10.5 ± 2.5
9.0 ± 2.5
1.25 ± 0.6
1.35 ± 0.6
6.0 ± 1.5
6.0 ± 1.5
Grace et al. [7]
Control (22)
Triathletes, athletics, sprint cyclists, racquet sports (17)
68.0 ± 14.0
70.0 ± 11.0
63.0 ± 15.0
54.0 ± 7.0
1.1 ± 0.3
1.3 ± 0.3
6.2 ± 1.3
7.4 ± 1.4
Maessen et al. [47]
Control (13)
Endurance athletes (18)
62.7 ± 15.7
63.0 ± 11.9
11.2 ± 2.0
11.3 ± 2.5
Maufrais et al. [49]
Control (20)
Cyclists (22)
69.7 ± 11.3
73.0 ± 15.7
9.1 ± 1.6
9.5 ± 2.6
7.8 ± 1.6
7.8 ± 2.0
Data are presented as mean ± standard deviation unless otherwise stated
Statistical significance at p < 0.05
A late diastolic mitral inflow velocity, a′ late diastolic tissue velocity, E early diastolic mitral inflow velocity, e′ early diastolic tissue velocity, e/a′ ratio of early to late diastolic tissue velocity, E/A ratio of early to late mitral inflow velocity, E/e′ ratio of early diastolic mitral inflow velocity to early diastolic tissue velocity, n participant number
Significantly greater in athletes
Significantly less in athletes
No athlete–control difference
Table 6
Meta-analyses of athlete–control differences for cardiac structure, systolic and diastolic function
Parameter
Number of studies
Difference in means
95% CI
p value
Heterogeneity
p value
Cochran’s Q
I2 statistic (%)
Cardiac structure
 IVS (mm)
18
1.23
0.85 to 1.60
< 0.01
78.42
78.32
< 0.01
 PWT (mm)
18
1.20
0.83 to 1.56
< 0.01
81.60
79.17
< 0.01
 LVEDD (mm)
23
3.65
2.66 to 4.64
< 0.01
64.99
66.15
< 0.01
 RWT
11
0.00
−0.02 to 0.03
0.73
51.89
80.73
< 0.01
 LVM (g)
10
72.03
45.70 to 98.36
< 0.01
211.29
95.74
< 0.01
 LVMi (g·m2)
20
28.17
19.84 to 36.49
< 0.01
148.62
87.22
< 0.01
 LVEDV (mL)
10
16.11
7.80 to 24.43
< 0.01
56.02
83.93
< 0.01
 LAD (mm)
5
2.07
−1.66 to 5.79
0.28
20.73
80.70
< 0.01
 RVEDD (mm)
3
3.49
−0.55 to 7.53
0.09
29.37
93.19
< 0.01
Left ventricular systolic function
 EF (%)
15
0.43
−1.57 to 2.44
0.67
82.90
83.11
< 0.01
 FS (%)
11
−0.34
−2.32 to 1.63
0.73
34.60
71.10
< 0.01
 SV (mL)
7
13.59
7.20 to 19.98
< 0.01
30.48
80.31
< 0.01
 s′ (cm·s−1)
14
0.09
−0.53 to 0.70
0.79
82.85
84.31
< 0.01
 GLS (%)
5
−0.04
−1.18 to 1.10
0.94
13.63
70.66
0.01
Left ventricular diastolic function
 E (cm·s−1)
22
2.08
−1.12 to 5.28
0.20
74.06
71.64
< 0.01
 A (cm·s−1)
20
−8.20
−11.90 to −4.51
< 0.01
68.73
72.36
< 0.01
 E/A
23
0.18
0.13 to 0.24
< 0.01
42.31
48.00
0.01
 e′ (cm·s−1)
14
0.96
0.05 to 1.86
0.04
93.55
86.10
< 0.01
 a′ (cm·s−1)
13
−0.72
−1.31 to −0.12
0.02
41.32
70.96
< 0.01
 e′/a
7
0.23
0.06 to 0.40
0.01
61.44
90.23
< 0.01
 E/e
8
0.23
−0.31 to 0.77
0.40
12.51
44.06
0.08
Bold values indicate statistical significance (p < 0.05)
A late diastolic mitral inflow velocity, a′ late diastolic tissue velocity, CI confidence interval, E early diastolic mitral inflow velocity, e′ early diastolic tissue velocity, e/a′ ratio of early to late diastolic tissue velocity, E/A ratio of early to late mitral inflow velocity, E/e′ ratio of early diastolic mitral inflow velocity to early diastolic tissue velocity, EF ejection fraction, FS fractional shortening, GLS global longitudinal strain, IVS interventricular septal, LAD left atrial diameter, LVEDD left ventricular end-diastolic diameter, LVEDV left ventricular end-diastolic volume, LVM left ventricular mass, LVMi left ventricular mass index, PWT posterior wall thickness, RVEDD right ventricular end-diastolic diameter, RWT relative wall thickness, s′ systolic tissue velocity, SV stroke volume

3.2 Cardiac Structure

IVS, PWT, LVEDD, LVEDV, LVM and LVMi were greater in athletes compared with controls, while RWT, RVEDD and LAD did not differ. Significant heterogeneity was observed for all parameters, with inconsistency considered moderate for LVEDD, yet high for IVS, PWT, RWT, LVM, LVMi, LVEDV RVEDD and LAD.

3.3 Left Ventricular Systolic Function

EF, FS, s′ and GLS were not different between athletes and controls, whereas SV was greater in athletes. Between-study heterogeneity was significant in all cases and the inconsistency considered moderate in FS and GLS, yet high for EF, s′ and SV.

3.4 Left Ventricular Diastolic Function

Pooled analysis of studies measuring mitral inflow velocity revealed no difference in E between athletes and controls, albeit A was significantly lower in athletes. Accordingly, E/A was greater in athletes compared with controls. Tissue velocity analyses showed higher e′ in athletes, whereas athletes showed significantly reduced a′ but greater e′/a′ compared with controls. E/e′ was not different between athletes and controls. Between-study heterogeneity was significant for all parameters of diastolic parameters besides E/e′. Inconsistency was low for E/A and E/e′, moderate for E, A and a′, and high for e′ and e′/a′.

3.5 Meta-Regression(s)

The difference between athletes and controls was maintained with chronological age for all available variables, with the exception of LVEDD, LVMi and A (Table 7). There was a significant inverse but opposite relationship in LVEDD, LVMi and A between athletes and controls that continued with chronological age.
Table 7
Meta-regression(s) of left ventricular structure and function between older athletes and controls during advancing age with interpretation
Covariate parameter
Number of studies
Cochran’s Q
SE
β
95% CI
p value
Interpretation (i.e. difference between athletes and controls with advancing age)
Left ventricular structure
 
 IVS
18
1.88
0.02
−0.04
−0.08 to 0.01
0.17
Maintained
 PWT
18
0.05
0.02
−0.005
−0.05 to 0.04
0.82
Maintained
 LVEDD
23
6.42
0.05
−0.14
−0.24 to −0.03
0.01
Reduced. The greater LVEDD in athletes reduced by ~ 0.14 mm per year relative to controls
 RWT
11
1.06
0.002
−0.002
−0.01 to 0.002
0.30
Maintained
 LVM
10
0.29
1.81
−0.97
−4.51 to 2.58
0.59
Maintained
 LVMi
20
9.79
0.57
−1.79
−2.91 to −0.67
< 0.01
Reduced. The greater LVMi in athletes reduced by ~ 1.79 g·m2 per year relative to controls
 LVEDV
10
0.44
0.62
0.41
−0.81 to 1.63
0.51
Maintained
Left ventricular systolic function
 
 EF
15
1.57
0.15
0.19
−0.11 to 0.48
0.21
Maintained
 FS
11
0.42
0.11
−0.07
−0.30 to 0.15
0.51
Maintained
 s
14
2.80
0.04
−0.07
−0.16 to 0.01
0.09
Maintained
Left ventricular diastolic function
 
 E
22
2.53
0.25
−0.40
−0.89 to 0.09
0.11
Maintained
 A
20
3.98
0.25
−0.50
−1.00 to −0.01
0.046
Increased. There was an increase of ~ 0.50 cm·s−1 per year in controls relative to athletes
 E/A
23
0.0001
0.004
0.00004
−0.01 to 0.01
0.99
Maintained
 e
14
0.41
0.06
−0.04
−0.17 to 0.09
0.52
Maintained
 a
13
1.03
0.04
−0.04
−0.12 to 0.04
0.31
Maintained
Bold values indicate statistical significance (p < 0.05)
A late diastolic mitral inflow velocity, a′ late diastolic tissue velocity, CI confidence interval, E early diastolic mitral inflow velocity, e′ early diastolic tissue velocity, E/A ratio of early to late mitral inflow velocity, EF ejection fraction, FS fractional shortening, IVS interventricular septal, LVEDD left ventricular end-diastolic diameter, LVEDV left ventricular end-diastolic volume, LVM left ventricular mass, LVMi left ventricular mass index, PWT posterior wall thickness, RWT relative wall thickness, s′ systolic tissue velocity, SE standard error

3.6 Publication Bias

Egger’s regression revealed that LVMi was the only variable which demonstrated significant bias (Electronic Supplementary Material Table S2).

4 Discussion

This first systematic pooling of controlled echocardiographic evidence of cardiac structure and function in aerobically (endurance) trained older athletes compared with age-matched untrained controls reveals that (1) endurance-trained older athletes have superior diastolic function compared with untrained counterparts, which is sustained regardless of advancing age; (2) mean LVM of older endurance athletes is greater (mean difference 72 g) than that of controls, as evidenced by greater wall thickness (mean ~ 1.2 mm) and chamber diameter (mean difference 3.7 mm); (3) despite modest differences in global systolic function between groups, older athletes have a larger SV (equivalent to mean difference ~ 1 L·min−1 greater cardiac output at rest) than controls, and this difference is sustained with chronological ageing.

4.1 Left Ventricular Diastolic Function

Older athletes enjoy more favourable global diastolic function which is driven by a reduced reliance on late diastolic filling and evident in both haemodynamic and tissue assessment. Greater E/A in aerobic athletes both contrasts [12] and concurs [13] with previous meta-analyses in younger cohorts. The E/A difference between groups shown here (mean difference 0.18) compares well with that reported for younger individuals (mean difference 0.2) by Utomi et al. [13], suggesting that the difference in global diastolic function between aerobically trained athletes and untrained controls is age independent. This is endorsed by the finding of the present meta-regression. Collectively, this supports the tenet that global diastolic function assessed by mitral inflow is preserved in athletes (versus controls) from ~ 18 to 74 years of age. The improved global diastolic function mediated by reductions in A, without concomitant changes in E, accords with a large investigation of young, Olympic calibre athletes [60], highlighting a similar adaptation in athletes of all ages compared with untrained controls. Moreover, meta-regression analysis observed that the difference in A between athletes and controls becomes more exaggerated with advancing age, which suggests an incremental reliance on atrial contraction to support LV filling in untrained controls.
Greater e′ in older trained adults agrees with findings from Utomi et al. [13] in younger athletes. In our meta-analysis, athletes demonstrated lower a′, and when considered with the observed difference in early diastole, a greater e′/a′ was observed in athletes than in controls. These observations support the precept that continuation of a high volume of aerobic exercise into advanced age has pleiotropic effects on cardiac function.

4.2 Cardiac Structure

Older athletes presented with larger LV wall thicknesses, absolute and relative LVMs, chamber diameter and LVEDV, which is comparable with findings from large-scale meta-analyses in younger athletes [12, 13]. This indicates preload dependent cardiac adaptation, widely considered as a normal cardiac manifestation from aerobic training [61], and these data suggest the maintenance of this phenomenon beyond 45 years. However, study-to-study variances in athlete and control blood pressures may have contributed towards the between-study heterogeneity observed, particularly for LVMi. Slower resting heart rates in athletes could also contribute to the increased LVEDD and LVEDV by lengthening the diastolic filling period. Furthermore, the meta-regression indicated no association between age and LVM, yet a significant, negative association with age and LVMi. The latter finding suggests that the differences in allometrically scaled LVM to BSA progressively decreased with advancing age, and supports a recent proposition that differences in LVMi between athletes and controls are dampened with advancing age [20]. The evidence that chronological age mediates LVMi in ageing athletes has not been convincing, with studies finding that younger, but not older athletes, have larger LVMi than age-matched controls [62] or older athletes do have a larger LVMi than controls yet this is to a lesser extent than younger athletes versus untrained controls [37, 63]. In contrast, others have shown a training effect with no interaction between age and training [29, 32, 49, 56]. Additionally, meta-regression showed the difference in LVEDD between athletes and controls decreases by a mean ~ 0.14 mm each year. Taking these findings together, we speculate that a gradual lowering of exercise intensity and/or training volume in older athletes [8], with a corresponding loss of volume overload, explains their inability to maintain physiological LVEDD and thus, ventricular mass, which is an established stimulus for physiological eccentric remodelling in those participating in isotonic exercise [64].
LAD was similar between athletes and controls, which contrasts with a prior meta-analysis showing larger LAD and volumes in younger athletes than in controls [17]. However, the results of this review may be considered preliminary given the relatively small number of studies available for the analysis of LA structure. Atrial morphology in older endurance athletes, relative to normal controls, requires further study and is of clinical interest given the ongoing debate concerning the potential interaction between atrial structural remodelling and the known larger incidence of atrial fibrillation in endurance athletes [65].
Similarly, RVEDD did not differ between older athletes and controls, which agrees with previous work in younger endurance athletes. Yet, two of the three studies in this meta-analysis observed larger RVEDD in athletes than in controls, highlighting a biventricular enlargement [30, 35] but significant heterogeneity between studies. This could be explained by age, as the participants in the studies showing RV dilation were younger than those in the study showing comparable diameter between athletes and controls [37]. Given the observed meta-regression of reduced mean difference LVEDD between athletes and controls with chronological age, it may be possible for a similar observation regarding the right-sided heart; however, more data are required before a sufficiently powered meta-regression can be conducted.

4.3 Left Ventricular Systolic Function

Conventional measures of LV systolic function, EF and FS were comparable between athletes and controls, as observed in younger cohorts [12, 13], which indicates preservation of resting EF and FS in older athletes. SV was greater in athletes than in controls and comparable with the literature for younger athletes [13]. In the absence of changes to EF, greater SV in athletes is likely a reflection of larger LVEDV and LVEDD [66], which is notably preserved despite increasing age.
Speckle tracking-derived GLS is a more sensitive marker of LV systolic (dys)function than conventionally measured EF [67]. However, GLS appeared to be unaltered between older aerobically trained athletes and controls, which agrees with the findings of a recent systematic synthesis of data for younger athletes [15]. There is emerging evidence that GLS is reduced in disease states [6870] and associated with poor cardiac outcomes [71]. Studies of younger [7274] and older individuals [75] have reported small increases in GLS after aerobic training programmes, and these are considered to be positive adaptations of the athlete’s heart [76]. However, with only five studies included in this meta-analysis, the small volume of work in older athletes requires expansion before more accurate estimations can be made, especially considering recent documentation of preserved GLS in lifelong exercisers, albeit in a mixed sex cohort [77].

4.4 Limitations

4.4.1 Available Studies

Within the present systematic search there was a single study of female athletes [78]. Due to this near absence of literature in ageing female athletes, the present findings should only be generalised to ageing men. Similarly, there were only two (potentially eligible) studies that examined resistance training (i.e. bodybuilding exercise) [35, 79] in ageing men, which precluded comparisons between the two most common exercise modes. In particular, more data are needed to fully characterise LA size in masters athletes, including diameter and volume, since varying degrees of lifelong training hours were associated with LA volume but not dimension [80]. The preponderance of studies of the LV and paucity of studies reporting on the RV limited our inclusion of RV indices, and therefore, a greater focus on the right side of the heart is warranted in older athletes. Future work should also include STE assessment of both left and right sides of the heart, to enable further insight into intrinsic cardiac mechanics.
Reporting of athlete training was inconsistent between studies, which prevented additional meta-regression analyses of training years, volume and intensity to further elucidate the between-study heterogeneity. Therefore, more robust documentation with quantitative means ± SDs is required before the influence of training regimes can be documented within a narrower age range, since cardiac structure and function have been reported to be exercise dose dependent [81]. Many studies did not state the specific sport performed by the athletes, or enrolled endurance athletes from different sports with varying magnitudes of static and dynamic loading. To allow subgroup analysis on the type of sport in future meta-analysis, we suggest studies report the sports of their athletes.

4.4.2 Present Meta-Analysis

This meta-analysis has notable limitations. Firstly, we were confined to analysing male participants. Further, we did not include other measures of body size-adjusted LV morphology (IVS, PWT, LVEDD). This was due to few data and inconsistent scaling within the literature. Of the included studies for LVMi, five used either height2.7 or fat-free mass to index LVM, which prevented separate meta-analysis and regression using these parameters for indexing other than BSA. It is noteworthy that two studies [34, 51] did not disclose the sex of participants. To resolve this, we employed an educated assumption of male participants because average LVEDD and LVEDV greatly exceeded the normal range in females [34]. This was further endorsed when average group LVMi data scaled to BSA were at the upper end of the range in men [23, 51] and vastly exceeded the expected range in females. We acknowledge that the data presented in this meta-analysis are derived from cross-sectional studies. However, there exists a paucity of prospective studies of sufficient duration to adequately quantify the influence of chronological age on the observed athlete–control differences, in addition to having relatively small sample sizes and mixed sexes. Indeed, 1 year of endurance training in older adults (> 65 years) did not alter LV stiffness and compliance [9], whereas recently, Howden et al. [82] observed reduced LV stiffness in middle-aged adults following 2 years of high-intensity training. While these data provide invaluable knowledge pertaining to the optimal stage of life to initiate exercise for offsetting the ageing process, the present findings document the benefit of exercise in those already trained across the age spectrum.

5 Conclusions

Pooled information from controlled echocardiography studies demonstrates that older athletes have superior global diastolic function compared with controls because of a reduced reliance on atrial contraction to LV filling in mitral inflow velocity and both increased early and reduced late diastolic tissue velocities. Furthermore, older athletes have notable differences in cardiac structure (wall thickness, cavity size and LV volume) with greater relative and absolute LVM. Despite unremarkable differences in LV systolic function, SV is markedly greater in older athletes. Notably, the present data also identify that masters athletes maintain these functional effects during chronological ageing.

Compliance with Ethical Standards

Funding

No sources of funding were used to assist in the preparation of this article.

Conflict of interest

Alexander Beaumont, Fergal Grace, Joanna Richards, Amy Campbell and Nicholas Sculthorpe declare that they have no conflicts of interest relevant to the content of this review.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Orthopädie & Unfallchirurgie

Kombi-Abonnement

Mit e.Med Orthopädie & Unfallchirurgie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Paffenbarger RS, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538–45.CrossRefPubMed Paffenbarger RS, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538–45.CrossRefPubMed
2.
Zurück zum Zitat Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation. 2003;107:3109–16.CrossRefPubMed Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation. 2003;107:3109–16.CrossRefPubMed
3.
Zurück zum Zitat Knowles A-M, Herbert P, Easton C, Sculthorpe N, Grace FM. Impact of low-volume, high-intensity interval training on maximal aerobic capacity, health-related quality of life and motivation to exercise in ageing men. Age Dordr Neth. 2015;37:25.CrossRef Knowles A-M, Herbert P, Easton C, Sculthorpe N, Grace FM. Impact of low-volume, high-intensity interval training on maximal aerobic capacity, health-related quality of life and motivation to exercise in ageing men. Age Dordr Neth. 2015;37:25.CrossRef
4.
Zurück zum Zitat Rogers MA, Hagberg JM, Martin WH, Ehsani AA, Holloszy JO. Decline in VO2max with aging in master athletes and sedentary men. J Appl Physiol. 1990;68:2195–9.CrossRefPubMed Rogers MA, Hagberg JM, Martin WH, Ehsani AA, Holloszy JO. Decline in VO2max with aging in master athletes and sedentary men. J Appl Physiol. 1990;68:2195–9.CrossRefPubMed
5.
Zurück zum Zitat Seals DR, Edward F. Adolph Distinguished Lecture: the remarkable anti-aging effects of aerobic exercise on systemic arteries. J Appl Physiol. 2014;117:425–39.CrossRefPubMedPubMedCentral Seals DR, Edward F. Adolph Distinguished Lecture: the remarkable anti-aging effects of aerobic exercise on systemic arteries. J Appl Physiol. 2014;117:425–39.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Shibata S, Fujimoto N, Hastings JL, Carrick-Ranson G, Bhella PS, Hearon CM, et al. The effect of lifelong exercise frequency on arterial stiffness. J Physiol. 2018;596:2783–95.CrossRefPubMedPubMedCentral Shibata S, Fujimoto N, Hastings JL, Carrick-Ranson G, Bhella PS, Hearon CM, et al. The effect of lifelong exercise frequency on arterial stiffness. J Physiol. 2018;596:2783–95.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Tanaka H, Seals DR. Endurance exercise performance in masters athletes: age-associated changes and underlying physiological mechanisms. J Physiol. 2008;586:55–63.CrossRefPubMed Tanaka H, Seals DR. Endurance exercise performance in masters athletes: age-associated changes and underlying physiological mechanisms. J Physiol. 2008;586:55–63.CrossRefPubMed
9.
Zurück zum Zitat Fujimoto N, Prasad A, Hastings JL, Arbab-Zadeh A, Bhella PS, Shibata S, et al. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation. 2010;122:1797–805.CrossRefPubMedPubMedCentral Fujimoto N, Prasad A, Hastings JL, Arbab-Zadeh A, Bhella PS, Shibata S, et al. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation. 2010;122:1797–805.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wilson M, O’Hanlon R, Basavarajaiah S, George K, Green D, Ainslie P, et al. Cardiovascular function and the veteran athlete. Eur J Appl Physiol. 2010;110:459–78.CrossRefPubMed Wilson M, O’Hanlon R, Basavarajaiah S, George K, Green D, Ainslie P, et al. Cardiovascular function and the veteran athlete. Eur J Appl Physiol. 2010;110:459–78.CrossRefPubMed
11.
Zurück zum Zitat Fagard RH. Athlete’s heart: a meta-analysis of the echocardiographic experience. Int J Sports Med. 1996;17(Suppl 3):S140–4.CrossRefPubMed Fagard RH. Athlete’s heart: a meta-analysis of the echocardiographic experience. Int J Sports Med. 1996;17(Suppl 3):S140–4.CrossRefPubMed
12.
Zurück zum Zitat Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete’s heart. A meta-analysis of cardiac structure and function. Circulation. 2000;101:336–44.CrossRefPubMed Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete’s heart. A meta-analysis of cardiac structure and function. Circulation. 2000;101:336–44.CrossRefPubMed
13.
Zurück zum Zitat Utomi V, Oxborough D, Whyte GP, Somauroo J, Sharma S, Shave R, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete’s heart. Heart. 2013;99:1727–33.CrossRefPubMed Utomi V, Oxborough D, Whyte GP, Somauroo J, Sharma S, Shave R, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete’s heart. Heart. 2013;99:1727–33.CrossRefPubMed
15.
Zurück zum Zitat Beaumont A, Grace F, Richards J, Hough J, Oxborough D, Sculthorpe N. Left ventricular speckle tracking-derived cardiac strain and cardiac twist mechanics in athletes: a systematic review and meta-analysis of controlled studies. Sports Med. 2017;47:1145–70.CrossRefPubMed Beaumont A, Grace F, Richards J, Hough J, Oxborough D, Sculthorpe N. Left ventricular speckle tracking-derived cardiac strain and cardiac twist mechanics in athletes: a systematic review and meta-analysis of controlled studies. Sports Med. 2017;47:1145–70.CrossRefPubMed
16.
Zurück zum Zitat D’Ascenzi F, Pelliccia A, Solari M, Piu P, Loiacono F, Anselmi F, et al. Normative reference values of right heart in competitive athletes: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2017;30(845–858):e2. D’Ascenzi F, Pelliccia A, Solari M, Piu P, Loiacono F, Anselmi F, et al. Normative reference values of right heart in competitive athletes: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2017;30(845–858):e2.
17.
Zurück zum Zitat Iskandar A, Mujtaba MT, Thompson PD. Left atrium size in elite athletes. JACC Cardiovasc Imaging. 2015;8:753–62.CrossRefPubMed Iskandar A, Mujtaba MT, Thompson PD. Left atrium size in elite athletes. JACC Cardiovasc Imaging. 2015;8:753–62.CrossRefPubMed
18.
Zurück zum Zitat Whyte GP, George K, Nevill A, Shave R, Sharma S, McKenna WJ. Left ventricular morphology and function in female athletes: a meta-analysis. Int J Sports Med. 2004;25:380–3.CrossRefPubMed Whyte GP, George K, Nevill A, Shave R, Sharma S, McKenna WJ. Left ventricular morphology and function in female athletes: a meta-analysis. Int J Sports Med. 2004;25:380–3.CrossRefPubMed
19.
Zurück zum Zitat Naylor LH, George K, O’Driscoll G, Green DJ. The athlete’s heart: a contemporary appraisal of the “Morganroth hypothesis”. Sports Med. 2008;38:69–90.CrossRefPubMed Naylor LH, George K, O’Driscoll G, Green DJ. The athlete’s heart: a contemporary appraisal of the “Morganroth hypothesis”. Sports Med. 2008;38:69–90.CrossRefPubMed
20.
Zurück zum Zitat Pavlik G, Major Z, Csajági E, Jeserich M, Kneffel Z. The athlete’s heart. Part II: influencing factors on the athlete’s heart: types of sports and age (review). Acta Physiol Hung. 2013;100:1–27.CrossRefPubMed Pavlik G, Major Z, Csajági E, Jeserich M, Kneffel Z. The athlete’s heart. Part II: influencing factors on the athlete’s heart: types of sports and age (review). Acta Physiol Hung. 2013;100:1–27.CrossRefPubMed
21.
Zurück zum Zitat Brown B, Green DJ, Wilson M, Drezner J, George K, Oxborough D. The complex phenotype of the athlete’s heart: implications for pre-participation screening. Exerc Sport Sci Rev. 2017;45:96–104.CrossRefPubMed Brown B, Green DJ, Wilson M, Drezner J, George K, Oxborough D. The complex phenotype of the athlete’s heart: implications for pre-participation screening. Exerc Sport Sci Rev. 2017;45:96–104.CrossRefPubMed
22.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–71.CrossRefPubMed Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–71.CrossRefPubMed
24.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107–33.CrossRefPubMed Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107–33.CrossRefPubMed
25.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.CrossRefPubMedPubMedCentral Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Baldi JC, McFarlane K, Oxenham HC, Whalley GA, Walsh HJ, Doughty RN. Left ventricular diastolic filling and systolic function of young and older trained and untrained men. J Appl Physiol. 2003;95:2570–5.CrossRefPubMed Baldi JC, McFarlane K, Oxenham HC, Whalley GA, Walsh HJ, Doughty RN. Left ventricular diastolic filling and systolic function of young and older trained and untrained men. J Appl Physiol. 2003;95:2570–5.CrossRefPubMed
30.
Zurück zum Zitat Bohm P, Schneider G, Linneweber L, Rentzsch A, Krämer N, Abdul-Khaliq H, et al. Right and left ventricular function and mass in male elite master athletes: a controlled contrast enhanced CMR study. Circulation. 2016;133(20):1927–35.CrossRefPubMed Bohm P, Schneider G, Linneweber L, Rentzsch A, Krämer N, Abdul-Khaliq H, et al. Right and left ventricular function and mass in male elite master athletes: a controlled contrast enhanced CMR study. Circulation. 2016;133(20):1927–35.CrossRefPubMed
31.
Zurück zum Zitat Bouvier F, Saltin B, Nejat M, Jensen-Urstad M. Left ventricular function and perfusion in elderly endurance athletes. Med Sci Sports Exerc. 2001;33:735–40.CrossRefPubMed Bouvier F, Saltin B, Nejat M, Jensen-Urstad M. Left ventricular function and perfusion in elderly endurance athletes. Med Sci Sports Exerc. 2001;33:735–40.CrossRefPubMed
32.
Zurück zum Zitat Carrick-Ranson G, Doughty RN, Whalley GA, Walsh HJ, Gamble GD, Baldi JC. The larger exercise stroke volume in endurance-trained men does not result from increased left ventricular early or late inflow or tissue velocities. Acta Physiol (Oxf). 2012;205:520–31.CrossRefPubMed Carrick-Ranson G, Doughty RN, Whalley GA, Walsh HJ, Gamble GD, Baldi JC. The larger exercise stroke volume in endurance-trained men does not result from increased left ventricular early or late inflow or tissue velocities. Acta Physiol (Oxf). 2012;205:520–31.CrossRefPubMed
33.
Zurück zum Zitat Child JS, Barnard RJ, Taw RL. Cardiac hypertrophy and function in master endurance runners and sprinters. J Appl Physiol. 1984;57:176–81.CrossRefPubMed Child JS, Barnard RJ, Taw RL. Cardiac hypertrophy and function in master endurance runners and sprinters. J Appl Physiol. 1984;57:176–81.CrossRefPubMed
34.
Zurück zum Zitat Cottini E, Giacone G, Cosentino M, Cirino A, Rando G, Vintaloro G. Evaluation of left ventricular diastolic function by pulmonary venous and mitral flow velocity patterns in endurance veteran athletes. Arch Gerontol Geriatr. 1996;22(Suppl 1):179–86.CrossRefPubMed Cottini E, Giacone G, Cosentino M, Cirino A, Rando G, Vintaloro G. Evaluation of left ventricular diastolic function by pulmonary venous and mitral flow velocity patterns in endurance veteran athletes. Arch Gerontol Geriatr. 1996;22(Suppl 1):179–86.CrossRefPubMed
35.
Zurück zum Zitat D’Andrea A, Caso P, Scarafile R, Salerno G, De Corato G, Mita C, et al. Biventricular myocardial adaptation to different training protocols in competitive master athletes. Int J Cardiol. 2007;115:342–9.CrossRefPubMed D’Andrea A, Caso P, Scarafile R, Salerno G, De Corato G, Mita C, et al. Biventricular myocardial adaptation to different training protocols in competitive master athletes. Int J Cardiol. 2007;115:342–9.CrossRefPubMed
36.
Zurück zum Zitat Di Bello V, Lattanzi F, Picano E, Talarico L, Caputo MT, Di Muro C, et al. Left ventricular performance and ultrasonic myocardial quantitative reflectivity in endurance senior athletes: an echocardiographic study. Eur Heart J. 1993;14:358–63.CrossRefPubMed Di Bello V, Lattanzi F, Picano E, Talarico L, Caputo MT, Di Muro C, et al. Left ventricular performance and ultrasonic myocardial quantitative reflectivity in endurance senior athletes: an echocardiographic study. Eur Heart J. 1993;14:358–63.CrossRefPubMed
37.
Zurück zum Zitat Donal E, Rozoy T, Kervio G, Schnell F, Mabo P, Carré F. Comparison of the heart function adaptation in trained and sedentary men after 50 and before 35 years of age. Am J Cardiol. 2011;108:1029–37.CrossRefPubMed Donal E, Rozoy T, Kervio G, Schnell F, Mabo P, Carré F. Comparison of the heart function adaptation in trained and sedentary men after 50 and before 35 years of age. Am J Cardiol. 2011;108:1029–37.CrossRefPubMed
38.
Zurück zum Zitat Fleg JL, Shapiro EP, O’Connor F, Taube J, Goldberg AP, Lakatta EG. Left ventricular diastolic filling performance in older male athletes. JAMA. 1995;273:1371–5.CrossRefPubMed Fleg JL, Shapiro EP, O’Connor F, Taube J, Goldberg AP, Lakatta EG. Left ventricular diastolic filling performance in older male athletes. JAMA. 1995;273:1371–5.CrossRefPubMed
39.
Zurück zum Zitat Galetta F, Franzoni F, Femia FR, Bartolomucci F, Carpi A, Santoro G. Left ventricular diastolic function and carotid artery wall in elderly athletes and sedentary controls. Biomed Pharmacother Biomed Pharmacother. 2004;58:437–42.CrossRefPubMed Galetta F, Franzoni F, Femia FR, Bartolomucci F, Carpi A, Santoro G. Left ventricular diastolic function and carotid artery wall in elderly athletes and sedentary controls. Biomed Pharmacother Biomed Pharmacother. 2004;58:437–42.CrossRefPubMed
40.
Zurück zum Zitat Galetta F, Franzoni F, Santoro G, Prattichizzo F, Femia FR, Pastine F, et al. QT dispersion in elderly athletes with left ventricular hypertrophy. Int J Sports Med. 2003;24:233–7.CrossRefPubMed Galetta F, Franzoni F, Santoro G, Prattichizzo F, Femia FR, Pastine F, et al. QT dispersion in elderly athletes with left ventricular hypertrophy. Int J Sports Med. 2003;24:233–7.CrossRefPubMed
41.
Zurück zum Zitat Gates PE, Tanaka H, Graves J, Seals DR. Left ventricular structure and diastolic function with human ageing. Relation to habitual exercise and arterial stiffness. Eur Heart J. 2003;24:2213–20.CrossRefPubMed Gates PE, Tanaka H, Graves J, Seals DR. Left ventricular structure and diastolic function with human ageing. Relation to habitual exercise and arterial stiffness. Eur Heart J. 2003;24:2213–20.CrossRefPubMed
42.
Zurück zum Zitat Giada F, Bertaglia E, De Piccoli B, Franceschi M, Sartori F, Raviele A, et al. Cardiovascular adaptations to endurance training and detraining in young and older athletes. Int J Cardiol. 1998;65:149–55.CrossRefPubMed Giada F, Bertaglia E, De Piccoli B, Franceschi M, Sartori F, Raviele A, et al. Cardiovascular adaptations to endurance training and detraining in young and older athletes. Int J Cardiol. 1998;65:149–55.CrossRefPubMed
43.
Zurück zum Zitat Jungblut PR, Osborne JA, Quigg RJ, McNeal MA, Clauser J, Muster AJ, et al. Echocardiographic Doppler evaluation of left ventricular diastolic filling in older, highly trained male endurance athletes. Echocardiography. 2000;17:7–16.CrossRefPubMed Jungblut PR, Osborne JA, Quigg RJ, McNeal MA, Clauser J, Muster AJ, et al. Echocardiographic Doppler evaluation of left ventricular diastolic filling in older, highly trained male endurance athletes. Echocardiography. 2000;17:7–16.CrossRefPubMed
44.
Zurück zum Zitat Kozàkovà M, Galetta F, Gregorini L, Bigalli G, Franzoni F, Giusti C, et al. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension. 2000;36:343–9.CrossRefPubMed Kozàkovà M, Galetta F, Gregorini L, Bigalli G, Franzoni F, Giusti C, et al. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension. 2000;36:343–9.CrossRefPubMed
45.
Zurück zum Zitat Lee LS, Mariani JA, Sasson Z, Goodman JM. Exercise with a twist: left ventricular twist and recoil in healthy young and middle-aged men, and middle-aged endurance-trained men. J Am Soc Echocardiogr. 2012;25:986–93.CrossRefPubMed Lee LS, Mariani JA, Sasson Z, Goodman JM. Exercise with a twist: left ventricular twist and recoil in healthy young and middle-aged men, and middle-aged endurance-trained men. J Am Soc Echocardiogr. 2012;25:986–93.CrossRefPubMed
48.
Zurück zum Zitat Matelot D, Schnell F, Kervio G, Ridard C, Thillaye du Boullay N, Wilson M, et al. Cardiovascular benefits of endurance training in seniors: 40 is not too late to start. Int J Sports Med. 2016;37:625–32.CrossRefPubMed Matelot D, Schnell F, Kervio G, Ridard C, Thillaye du Boullay N, Wilson M, et al. Cardiovascular benefits of endurance training in seniors: 40 is not too late to start. Int J Sports Med. 2016;37:625–32.CrossRefPubMed
50.
Zurück zum Zitat Maufrais C, Schuster I, Doucende G, Vitiello D, Rupp T, Dauzat M, et al. Endurance training minimizes age-related changes of left ventricular twist-untwist mechanics. J Am Soc Echocardiogr. 2014;27:1208–15.CrossRefPubMed Maufrais C, Schuster I, Doucende G, Vitiello D, Rupp T, Dauzat M, et al. Endurance training minimizes age-related changes of left ventricular twist-untwist mechanics. J Am Soc Echocardiogr. 2014;27:1208–15.CrossRefPubMed
51.
Zurück zum Zitat Miki T, Yokota Y, Seo T, Yokoyama M. Echocardiographic findings in 104 professional cyclists with follow-up study. Am Heart J. 1994;127:898–905.CrossRefPubMed Miki T, Yokota Y, Seo T, Yokoyama M. Echocardiographic findings in 104 professional cyclists with follow-up study. Am Heart J. 1994;127:898–905.CrossRefPubMed
52.
Zurück zum Zitat Molmen HE, Wisloff U, Aamot IL, Stoylen A, Ingul CB. Aerobic interval training compensates age related decline in cardiac function. Scand Cardiovasc J. 2012;46:163–71.CrossRefPubMed Molmen HE, Wisloff U, Aamot IL, Stoylen A, Ingul CB. Aerobic interval training compensates age related decline in cardiac function. Scand Cardiovasc J. 2012;46:163–71.CrossRefPubMed
53.
Zurück zum Zitat Nishimura T, Yamada Y, Kawai C. Echocardiographic evaluation of long-term effects of exercise on left ventricular hypertrophy and function in professional bicyclists. Circulation. 1980;61:832–40.CrossRefPubMed Nishimura T, Yamada Y, Kawai C. Echocardiographic evaluation of long-term effects of exercise on left ventricular hypertrophy and function in professional bicyclists. Circulation. 1980;61:832–40.CrossRefPubMed
54.
Zurück zum Zitat Northcote RJ, McKillop G, Todd IC, Canning GP. The effect of habitual sustained endurance exercise on cardiac structure and function. Eur Heart J. 1990;11:17–22.CrossRefPubMed Northcote RJ, McKillop G, Todd IC, Canning GP. The effect of habitual sustained endurance exercise on cardiac structure and function. Eur Heart J. 1990;11:17–22.CrossRefPubMed
55.
Zurück zum Zitat Nottin S, Nguyen L-D, Terbah M, Obert P. Long-term endurance training does not prevent the age-related decrease in left ventricular relaxation properties. Acta Physiol Scand. 2004;181:209–15.CrossRefPubMed Nottin S, Nguyen L-D, Terbah M, Obert P. Long-term endurance training does not prevent the age-related decrease in left ventricular relaxation properties. Acta Physiol Scand. 2004;181:209–15.CrossRefPubMed
56.
Zurück zum Zitat Olsen RH, Couppé C, Dall CH, Monk-Hansen T, Mikkelsen UR, Karlsen A, et al. Age-related decline in mitral peak diastolic velocities is unaffected in well-trained runners. Scand Cardiovasc J. 2015;49:183–92.CrossRefPubMed Olsen RH, Couppé C, Dall CH, Monk-Hansen T, Mikkelsen UR, Karlsen A, et al. Age-related decline in mitral peak diastolic velocities is unaffected in well-trained runners. Scand Cardiovasc J. 2015;49:183–92.CrossRefPubMed
57.
Zurück zum Zitat Sagiv M, Goldhammer E, Ben-Sira D, Amir R. What maintains energy supply at peak aerobic exercise in trained and untrained older men? Gerontology. 2007;53:357–61.CrossRefPubMed Sagiv M, Goldhammer E, Ben-Sira D, Amir R. What maintains energy supply at peak aerobic exercise in trained and untrained older men? Gerontology. 2007;53:357–61.CrossRefPubMed
58.
Zurück zum Zitat Schmidt JF, Andersen TR, Andersen LJ, Randers MB, Hornstrup T, Hansen PR, et al. Cardiovascular function is better in veteran football players than age-matched untrained elderly healthy men. Scand J Med Sci Sports. 2015;25:61–9.CrossRefPubMed Schmidt JF, Andersen TR, Andersen LJ, Randers MB, Hornstrup T, Hansen PR, et al. Cardiovascular function is better in veteran football players than age-matched untrained elderly healthy men. Scand J Med Sci Sports. 2015;25:61–9.CrossRefPubMed
59.
Zurück zum Zitat Seals DR, Hagberg JM, Spina RJ, Rogers MA, Schechtman KB, Ehsani AA. Enhanced left ventricular performance in endurance trained older men. Circulation. 1994;89:198–205.CrossRefPubMed Seals DR, Hagberg JM, Spina RJ, Rogers MA, Schechtman KB, Ehsani AA. Enhanced left ventricular performance in endurance trained older men. Circulation. 1994;89:198–205.CrossRefPubMed
60.
Zurück zum Zitat Caselli S, Di Paolo FM, Pisicchio C, Pandian NG, Pelliccia A. Patterns of left ventricular diastolic function in Olympic athletes. J Am Soc Echocardiogr. 2015;28:236–44.CrossRefPubMed Caselli S, Di Paolo FM, Pisicchio C, Pandian NG, Pelliccia A. Patterns of left ventricular diastolic function in Olympic athletes. J Am Soc Echocardiogr. 2015;28:236–44.CrossRefPubMed
61.
Zurück zum Zitat Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82:521–4.CrossRefPubMed Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82:521–4.CrossRefPubMed
62.
Zurück zum Zitat Pavlik G, Olexó Z, Osváth P, Sidó Z, Frenkl R. Echocardiographic characteristics of male athletes of different age. Br J Sports Med. 2001;35:95–9.CrossRefPubMedPubMedCentral Pavlik G, Olexó Z, Osváth P, Sidó Z, Frenkl R. Echocardiographic characteristics of male athletes of different age. Br J Sports Med. 2001;35:95–9.CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Teske AJ, Prakken NH, De Boeck BWL, Velthuis BK, Doevendans PA, Cramer MJM. Effect of long term and intensive endurance training in athletes on the age related decline in left and right ventricular diastolic function as assessed by Doppler echocardiography. Am J Cardiol. 2009;104:1145–51.CrossRefPubMed Teske AJ, Prakken NH, De Boeck BWL, Velthuis BK, Doevendans PA, Cramer MJM. Effect of long term and intensive endurance training in athletes on the age related decline in left and right ventricular diastolic function as assessed by Doppler echocardiography. Am J Cardiol. 2009;104:1145–51.CrossRefPubMed
64.
Zurück zum Zitat Kovacs R, Baggish AL. Cardiovascular adaptation in athletes. Trends Cardiovasc Med. 2016;26:46–52.CrossRefPubMed Kovacs R, Baggish AL. Cardiovascular adaptation in athletes. Trends Cardiovasc Med. 2016;26:46–52.CrossRefPubMed
65.
Zurück zum Zitat Elliott AD, Linz D, Verdicchio CV, Sanders P. Exercise and atrial fibrillation: prevention or causation? Heart Lung Circ. 2018;27:1078–85.CrossRefPubMed Elliott AD, Linz D, Verdicchio CV, Sanders P. Exercise and atrial fibrillation: prevention or causation? Heart Lung Circ. 2018;27:1078–85.CrossRefPubMed
66.
Zurück zum Zitat Rowland T. Endurance athletes’ stroke volume response to progressive exercise. Sports Med. 2009;39:687–95.CrossRefPubMed Rowland T. Endurance athletes’ stroke volume response to progressive exercise. Sports Med. 2009;39:687–95.CrossRefPubMed
67.
Zurück zum Zitat Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37:1196–207.CrossRefPubMed Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37:1196–207.CrossRefPubMed
68.
Zurück zum Zitat Galderisi M, Lomoriello VS, Santoro A, Esposito R, Olibet M, Raia R, et al. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2010;23:1190–8.CrossRefPubMed Galderisi M, Lomoriello VS, Santoro A, Esposito R, Olibet M, Raia R, et al. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2010;23:1190–8.CrossRefPubMed
69.
Zurück zum Zitat Santoro A, Alvino F, Antonelli G, Zacà V, Benincasa S, Lunghetti S, et al. Left ventricular twisting modifications in patients with left ventricular concentric hypertrophy at increasing after-load conditions. Echocardiography. 2014;31:1265–73.CrossRefPubMed Santoro A, Alvino F, Antonelli G, Zacà V, Benincasa S, Lunghetti S, et al. Left ventricular twisting modifications in patients with left ventricular concentric hypertrophy at increasing after-load conditions. Echocardiography. 2014;31:1265–73.CrossRefPubMed
70.
Zurück zum Zitat Butz T, van Buuren F, Mellwig KP, Langer C, Plehn G, Meissner A, et al. Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2011;27:91–100.CrossRefPubMed Butz T, van Buuren F, Mellwig KP, Langer C, Plehn G, Meissner A, et al. Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2011;27:91–100.CrossRefPubMed
72.
Zurück zum Zitat Weiner RB, Hutter AM, Wang F, Kim J, Weyman AE, Wood MJ, et al. The impact of endurance exercise training on left ventricular torsion. JACC Cardiovasc Imaging. 2010;3:1001–9.CrossRefPubMed Weiner RB, Hutter AM, Wang F, Kim J, Weyman AE, Wood MJ, et al. The impact of endurance exercise training on left ventricular torsion. JACC Cardiovasc Imaging. 2010;3:1001–9.CrossRefPubMed
73.
Zurück zum Zitat Aksakal E, Kurt M, Ozturk ME, Tanboga IH, Kaya A, Nacar T, et al. The effect of incremental endurance exercise training on left ventricular mechanics: a prospective observational deformation imaging study. Anadolu Kardiyol Derg Anatol J Cardiol [Internet]. 2013. http://anatoljcardiol.com/jvi.aspx?un = AJC-25238. Accessed 7 Dec 2016. Aksakal E, Kurt M, Ozturk ME, Tanboga IH, Kaya A, Nacar T, et al. The effect of incremental endurance exercise training on left ventricular mechanics: a prospective observational deformation imaging study. Anadolu Kardiyol Derg Anatol J Cardiol [Internet]. 2013. http://​anatoljcardiol.​com/​jvi.​aspx?​un =​ AJC-25238. Accessed 7 Dec 2016.
74.
Zurück zum Zitat D’Ascenzi F, Pelliccia A, Alvino F, Solari M, Loffreno A, Cameli M, et al. Effects of training on LV strain in competitive athletes. Heart Br Card Soc. 2015;101:1834–9. D’Ascenzi F, Pelliccia A, Alvino F, Solari M, Loffreno A, Cameli M, et al. Effects of training on LV strain in competitive athletes. Heart Br Card Soc. 2015;101:1834–9.
75.
Zurück zum Zitat Schmidt JF, Hansen PR, Andersen TR, Andersen LJ, Hornstrup T, Krustrup P, et al. Cardiovascular adaptations to 4 and 12 months of football or strength training in 65- to 75-year-old untrained men. Scand J Med Sci Sports. 2014;24(Suppl 1):86–97.CrossRefPubMed Schmidt JF, Hansen PR, Andersen TR, Andersen LJ, Hornstrup T, Krustrup P, et al. Cardiovascular adaptations to 4 and 12 months of football or strength training in 65- to 75-year-old untrained men. Scand J Med Sci Sports. 2014;24(Suppl 1):86–97.CrossRefPubMed
76.
Zurück zum Zitat D’Ascenzi F, Caselli S, Solari M, Pelliccia A, Cameli M, Focardi M, et al. Novel echocardiographic techniques for the evaluation of athletes’ heart: a focus on speckle-tracking echocardiography. Eur J Prev Cardiol. 2016;23:437–46.CrossRefPubMed D’Ascenzi F, Caselli S, Solari M, Pelliccia A, Cameli M, Focardi M, et al. Novel echocardiographic techniques for the evaluation of athletes’ heart: a focus on speckle-tracking echocardiography. Eur J Prev Cardiol. 2016;23:437–46.CrossRefPubMed
77.
Zurück zum Zitat Howden EJ, Carrick-Ranson G, Sarma S, Hieda M, Fujimoto N, Levine BD. Effects of sedentary aging and lifelong exercise on left ventricular systolic function. Med Sci Sports Exerc. 2017;50:494–501.CrossRef Howden EJ, Carrick-Ranson G, Sarma S, Hieda M, Fujimoto N, Levine BD. Effects of sedentary aging and lifelong exercise on left ventricular systolic function. Med Sci Sports Exerc. 2017;50:494–501.CrossRef
78.
Zurück zum Zitat Hagmar M, Hirschberg AL, Lindholm C, Schenck-Gustafsson K, Eriksson MJ. Athlete’s heart in postmenopausal former elite endurance female athletes. Clin J Sport Med. 2005;15:257–62.CrossRefPubMed Hagmar M, Hirschberg AL, Lindholm C, Schenck-Gustafsson K, Eriksson MJ. Athlete’s heart in postmenopausal former elite endurance female athletes. Clin J Sport Med. 2005;15:257–62.CrossRefPubMed
79.
Zurück zum Zitat Haykowsky MJ, Quinney HA, Gillis R, Thompson CR. Left ventricular morphology in junior and master resistance trained athletes. Med Sci Sports Exerc. 2000;32:349–52.CrossRefPubMed Haykowsky MJ, Quinney HA, Gillis R, Thompson CR. Left ventricular morphology in junior and master resistance trained athletes. Med Sci Sports Exerc. 2000;32:349–52.CrossRefPubMed
80.
Zurück zum Zitat Elliott AD, Mahajan R, Linz D, Stokes M, Verdicchio CV, Middeldorp ME, et al. Atrial remodeling and ectopic burden in recreational athletes: implications for risk of atrial fibrillation. Clin Cardiol. 2018;41:843–8.CrossRefPubMedPubMedCentral Elliott AD, Mahajan R, Linz D, Stokes M, Verdicchio CV, Middeldorp ME, et al. Atrial remodeling and ectopic burden in recreational athletes: implications for risk of atrial fibrillation. Clin Cardiol. 2018;41:843–8.CrossRefPubMedPubMedCentral
81.
Zurück zum Zitat Bhella PS, Hastings JL, Fujimoto N, Shibata S, Carrick-Ranson G, Palmer MD, et al. Impact of lifelong exercise “dose” on left ventricular compliance and distensibility. J Am Coll Cardiol. 2014;64:1257–66.CrossRefPubMedPubMedCentral Bhella PS, Hastings JL, Fujimoto N, Shibata S, Carrick-Ranson G, Palmer MD, et al. Impact of lifelong exercise “dose” on left ventricular compliance and distensibility. J Am Coll Cardiol. 2014;64:1257–66.CrossRefPubMedPubMedCentral
82.
Zurück zum Zitat Howden EJ, Sarma S, Lawley JS, Opondo M, Cornwell W, Stoller D, et al. Reversing the cardiac effects of sedentary aging in middle age—a randomized controlled trial: Implications for heart failure prevention. Circulation. 2018;137(15):1549–60.CrossRefPubMedPubMedCentral Howden EJ, Sarma S, Lawley JS, Opondo M, Cornwell W, Stoller D, et al. Reversing the cardiac effects of sedentary aging in middle age—a randomized controlled trial: Implications for heart failure prevention. Circulation. 2018;137(15):1549–60.CrossRefPubMedPubMedCentral
Metadaten
Titel
Aerobic Training Protects Cardiac Function During Advancing Age: A Meta-Analysis of Four Decades of Controlled Studies
verfasst von
Alexander J. Beaumont
Fergal M. Grace
Joanna C. Richards
Amy K. Campbell
Nicholas F. Sculthorpe
Publikationsdatum
29.10.2018
Verlag
Springer International Publishing
Erschienen in
Sports Medicine / Ausgabe 2/2019
Print ISSN: 0112-1642
Elektronische ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-018-1004-3

Weitere Artikel der Ausgabe 2/2019

Sports Medicine 2/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.